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ABSTRACT

Babbs, Charles Frederick, Ph.D., Drug Induced Changes in
Ventricular Defibrillation Threshold, December 1977.
Major Professors: G.K.W. Yim and L.A. Geddes.
A theory is developed that the minimal current required
for electrical ventricular defibrillation (the defibrillation threshold) is proportional to the gap between the
resting transmembrane potential and the threshold transmembrane potential of myocardial cells.

This voltage gap

is, in turn, related to the sodium conductance (gNa)
and the potassium conductance (gK) of the membrane and to
the transmembrane equilibrium potentials for sodium (ENa)
and potassium (EK) .

To test the theory pharmacologic

studies were performed.

First, the stability and precision

of control data and, second, the effect upon defibrillation
threshold of quinidine (which alters gNa), lidocaine (which
alters gK), and potassium chloride (which alters EK) were
evaluated in pentobarbital-anesthetized dogs.

Threshold

was determined by repeated trials of fibrillation and defibrillation with successive damped sinusoidal shocks of
diminishing current intensity, each 10 percent less than
the preceding shock.
fibrillated

The lowest shock intensity that de-

was defined as threshold.
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Threshold current and energy in five dogs averaged 2
percent and 13 percent

less,~~Sfectively,under

surgical levels

of pentobarbital anesthesia than thresholds in the same
animals in the awake, unanesthetized state.

In dogs given

sufficient pentobarbital to produce apnea and supported by
mechanical ventilation, threshold current and energy averaged 3 percent and 17 percent less than comparable awake
values.
cant.

These differences were not statistically signifiPentobarbital was consequently

selected as the

anesthetic for defibrillation studies.
Over 200 measurements of ventricular defibrillation
threshold were made to determine the stability and
precision of threshold data.

In three groups of five dogs

each, threshold was measured at intervals of 60, 15, and
5 minutes over periods of 8, 5, and 1 hour, respectively.
Similar results were obtained for all groups.

There was

no significant change in mean threshold current with time.
Due to a decrease in transchest impedance, threshold
delivered energy decreased by 10 percent during the first
hour of testing.

Standard deviations for threshold peak

current and delivered energy in a given animal were 11 and
22 percent of their respective mean values.

Arterial blood

pH, pco , and po averaged 7.38, 34 mmHg, and 72 mmHg,
2
2
respectively.

The rates of change of pH, pco , and po
2
2

were not significantly different from zero.

Ventricular

defibrillation threshold is therefore a stable

ix

physiologic parameter which may be measured with
reasonable precision for pharmacologic studies.
Drug effects on threshold delivered energy and peak
current, expressed as percentages of pre-drug threshold,
are given in the table.

Table entries indicate maximal

changes in mean defibrillation threshold.

Treatment

Delivered
Energy

Peak
Current

Quinidine (50 mg/kg, i.v.)

272

145

Lidocaine (3 mg/kg, i.v.)

148

126

Lidocaine ( 0. 5 mg/kg/min i. v. ,
40 mg/kg total dose)

199

145

65

82

Elevation of plasma K to 16.6
mEq/1 by KCl infusion

0

0

Pentobarbital only (controls)

101

104

Elevation of plasma K to
7.5 mEq/1 by KCl infusion

Observed drug effects are consistent with theoretical
predictions that drugs \vhich decrease gNa or increase gK
increase defibrillation threshold and drugs which make EK
less negative decrease defibrillation threshold.
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CHAPTER 1
BACKGROUND AND THEORY

Statement of the Problem
The studies described in this thesis were conducted
to determine the manner in which selected drugs influence
the electric shock intensity required for ventricular
defibrillation.

Electrical defibrillation, the application

of a strong electric shock to the heart, is the only safe
and effective therapy for ventricular fibrillation, an
otherwise lethal cardiac rhythm.

In theory, the passage

of an electric shock on the order of 100 ma/cm

2

through

the ventricules for 2-30 msec will simultaneously
stimulate most ventricular muscle cells, causing potentially excitable cells to be refractory for a brief
interval thereafter.

This intervention stops the self-

propagation of the multiple random waves of excitation
which constitute fibrillation.

The minimum shock intensity

required to produce defibrillation is defined as the
"defibrillation threshold."

In Chapter 1 of this thesis

a theory is developed which states that defibrillation
threshold is determined by the difference between the
resting transmembrane

electrical potential and the

2

firing or threshold potential of individual myocardial
cells.

Drugs which act at the cellular level to narrow

the gap between the resting potential and firing potential
of working myocardial cells would be expected to decrease
the electrical defibrillation threshold.

Obversely, drugs

which widen this gap would be expected to increase
defibrillation threshold.

Further theoretical analysis

based upon fundamental principles of membrane physiology
indicates that drugs which alter the sodium or potassium
conductance of cell membranes, or the ratio of intracellular
to extracellular sodium or potassium concentration should
alter the difference between the resting potential and
firing potential of cardiac cells and in turn alter the
defibrillation threshold.
The present research, therefore, includes three
aspects: first, development of a theory which predicts in
a semiquantitative fashion the electrical shock intensity
for defibrillation and the possible mechanisms by which
drug treatments could alter the threshold; second, the
development of a suitable animal model for experimental
investigation of drug effects on ventricular defibrillation
threshold; and third, the comparison of experimentally
produced drug effects with theoretical predictions.
Chapters 1, 2, and 3 deal respectively with these aspects
of the problem.

3

Mechanisms of Fibrillation
Ventricular fibrillation, the most dangerous cardiac
arrhythmia, is a common immediate cause of death in
patients with heart, lung, or kidney disease.

During this

arrhythmia, there is random, uncoordinated contraction of
multiple areas of muscle in the cardiac ventricles.

When

viewed directly, the heart appears as a shimmering mass of
tissue.

Upon close inspection multiple, unsynchronized

waves of contraction and relaxation can be seen traversing
the ventricular surface in random directions.

As a result

of this arrhythmia no blood is pumped and circulation to
the brain, the heart itself, and other vital organs comes
to a standstill.

Ventricular fibrillation causes certain

death if resuscitative measures and definitive therapy are
not begun within three to five minutes {Stephenson, 1974).
Circulation adequate to sustain life may be maintained for
up to several hours by massage of the fibrillating ventricles, using open or closed chest techniques in conjunction
with artificial ventilation.

However, spontaneous de-

fibrillation of the ventricles virtually never occurs in
humans.
The Circus Motion Theory
The simplest theory describing a mechanism for ventricular fibrillation is the circus motion theory of Garrey
{1914).

Development of a "circus motion" may be demon-

strated in rings of myocardium such as those illustrated

4

in Figure 1-1.

Such rings were created by Mines (1913)

by cutting the atria of the ray fish and by Garrey (1914)
by cutting the turtle ventricle.

Such a ring of mammalian

ventricle is normally excited by Purkinje fibers which first
stimulate subendocardial muscle fibers.

The impulse then

spreads from subendocardial muscle to the epicardial
surface (Figure 1-l(a)).

Further spread of the impulse is

impossible because ventricular muscle is refractory for
about 300 msec.

Hence such a normally conducted impulse

cannot become self-propagating.
A typical premature ventricular contraction (PVC) is
likewise not self-propagating.

An impulse arising from a

single focus in the ventricular wall and spreading in all
directions will coalesce on the side of the heart opposite
its origin and annihilate itself due to the refractoriness
of the converging masses of recently excited tissue
(Figure 1-1

(~J))

•

In injured hearts containing patchy areas of refractoriness during early diastole, however, PVCs are
more dangerous.

In Figure 1-l(c) an impulse arising from

an irritable focus at the edge of an injured area is blocked
in one direction due to prolonged refractory period in
the injured tissue.

The impulse therefore travels only

clockwise around the ventricular wall.

Traveling at 50

em/sec such an impulse would close the loop around a 5 em
diameter ventricle (16 em in circumference) in 320 msec,

5

IRRITABLE

IRRITABLE
TRANSIENTLY
REFRACTORY
AREA

:

I

i

I

(c)

Figure 1-l.

Development of circus motions in rings of
ventricular myocardium.
(a) Normal excitation
via subendocardial Purkinje fibers.
(b) Excitation during a typical PVC, originating at
an irritable focus.
(c) Excitation by a PVC
originating at the edge of a transiently refractory area, leading to a self-perpetuating
circus motion.
(d) Development of a circus
motion in a dilated heart.
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adequate time for the muscle first stimulated by the PVC
to recover sufficiently to be excited by the "reentrant"
impulse.

Under these conditions, a self-propagated "circus

motion" would develop, that is, the impulse would be conducted around and around the myocardium.
The time available for recovery of the initially
excited myocardium and the probability of development of
circus motions are enhanced in failing hearts which are
both injured and dilated.

In such hearts, the path length

of potential circus motions is increased (Figure 1-l(d)).
For example, in a dilated 8 em diameter ventricle (25 em in
circumference) , a blocked unidirectional impulse would
require 500 msec to travel completely around the wall,
allowing ample time for recovery of initially refractory
fibers.
The Impulse Wavelength
From Figure 1-1 it is evident that the impulse conduction velocity multiplied by the refractory period gives
the length of the strip of refractory myocardium.

The

product of conduction velocity and effective refractory
period may be defined as the "wavelength" of the impulse
of depolarization.

A normal value for the impulse wave-

length in mammals is about 10-30 em (Hoffman and
Cranefield, 1960).

As illustrated in Figure 1-l(d), if

the impulse wavelength is less than the ventricular
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circumference then the development of circus movements
becomes possible, especially in the presence of patchy
areas of refractoriness caused by ischemia, cooling, or
rapid, repetitive stimulation.

On the other hand, small

hearts of circumference less than 10-30 em (diameter less
than 3-10 em) may be unable to sustain fibrillation according to the circus motion theory.

Rabbits possess hearts

with dimensions equal to or below the theoretical limit
for circus motion, and indeed smaller rabbit hearts will
not sustain fibrillation at normal body temperatures
whereas larger rabbit hearts may fibrillate

(Geddes, 1977).

The Relation of Circus Motions to Fibrillation
If a circus motion of the type diagrammed in Figure
1-1 occurred circumferentially about the long axis of a
left ventricle composed of uniformly excitable tissue,
the rhythm known as ventricular flutter would be present.
Ventricular flutter usually exists only for a short time
and usually degenerates into fibrillation.

Because of the

asymmetrical geometry of the heart, the depolarization
wavefront of a circus motion soon breaks up into multiple
wavefronts upon encountering the junction between right
ventricular free wall and interventricular septum, the
mitral and tricuspid valve rings, or islands of refractory
tissue.

The closed-loop pathways permitting ventricular

re-excitation become multiple, convuluted, and everchanging as true ventricular fibrillation develops.

8

The Ectopic Focus Theory
The ectopic focus theory concerning the electrical
events leading to fibrillation was proposed by Scherf and
Terranova (1944).

They postulated that rapid, repetitive

excitations arise spontaneously from hyperirritable foci of
myocardium to which the cardiac tissue is unable to respond
in a synchronous fashion.

Friedberg (1966) has suggested

several mechanisms by which such ectopic foci could arise.
First, several of the areas of latent pacemaker tissue
might become active simultaneously, for example, in response
to beta adrenergic hormones.

Second, electrical potentials

might be created between different areas of cells, resulting
in stimulation of the fibers.

Such potentials might

develop if some cells were damaged, and maintained
resting membrane potentials less than the potentials found
in normal adjacent fibers.

Finally, cells which do not

normally act as pacemakers might become pacemakers under
pathological circumstances.

Heart size is also an important

factor in the multiple pacemaker theory, in that the
likelihood of multiple pacemaker sites increases when
larger masses of tissue are available.

Both the circus

motion theory and the ectopic focus theory may be invoked
to improve one's understanding of the phenomenon of
ventricular fibrillation.

The ectopic focus theory

emphasizes pathophysiologic factors which can initiate
ventricular fibrillation.

The circus motion theory
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emphasizes pathophysiologic factors w·hich lead to the
perpetuation of ventricular fibrillation.

A synthesis of

both theories is therefore possible in which the presence
of ectopic foci in sufficiently large hearts may lead to the
phenomenon of sustained ventricular fibrillation.
Hechanisns of Defibrillation
Application of a strong, electric shock to the heart
is the only dependable and definitive therapy for
ventricular fibrillation.

When properly applied, this

shock causes all heart muscle fibers to cease contracting
and stops the fibrillation.

Usually, within a few seconds

after the shock, a normal pacemaker will begin triggering
synchronous ventricular contractions and cardiac pumping
is resumed.
The phenomenon of electrical ventricular defibrillation
was first reported by Prevost and Battelli (1899 a-d).
However, interest in the phenomenon was not revived until
after Hooker (1930) had developed the chemical method of
defibrillation.

This method, which was used

~:;vhen

appro-

priate in clinical medicine until the late 1950s, involved
injecting KCl solution directly into the left ventricle.
Massage of the heart, especially with occlusion of the
thoracic aorta, forced the potassium solution into the
coronary circulation.

This achieved defibrillation but

also left the heart completely hypodynamic.

Therefore,

10

CaC1
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solution was next injected into the left ventricle

and massaged into the coronary bed to expel the KCl and
counteract its depressant effect.

Subsequently Hooker,

Kouwenhoven, and Langworthy (1933) came upon the Prevost
and Battelli papers and confirmed that although low
intensity alternating current shocks produced ventricular
fibrillation, higher intensity shocks could arrest fibrillation.

After over a decade, the technique of 60 Hz alterna-

ting current defibrillation was introduced into clinical
medicine by Beck (1947), using electrodes applied directly
to the heart,and Zoll (1956), using transchest electrodes.
Thereafter several investigators including Gurvich (1947),
Kouwenhoven (1954), and Lown (1962) discovered that, compared to alternating current shocks, a brief direct current
shock provided by discharge of a capacitor or a capacitor
in series with an inductor could also defibrillate the atria
with less danger of producing ventricular fibrillation at low
shock intensity.

These studies led to the development of

modern defibrillators, most of which contain a capacitor
and an inductor.

The capacitor is charged by a direct current

power supply to a preset voltage.

At the time of de-

fibrillation, the capacitor is switched in series with the
inductor and the subject.

A heavily damped sinusoidal

pulse of current lasting 2-10 msec is thereby delivered.
If the current passes through a critical mass of myocardium

ll

and is of sufficient intensity, defibrillation is
routinely achieved.
The Electrophysiologic Requirement for Defibrillation
The effect of current delivered by defibrillators
upon the cellular electrophysiology of the heart has not
yet been studied directly.

This section presents a theory

which indicates that although extremely high currents and
voltages appear across the heart and thorax during defibrillation, the stimulus at the cellular level is
physiologic, and inherently nontoxic if properly applied.
Moreover, the hypothesis supports the notion that the
actions of drugs upon transmembrane ionic conductances and
equilibrium potentials should influence the effectiveness
of electrical ventricular defibrillation.
The fundamental tenet of the hypothesis is that the
essential requirement for defibrillation is excitation of
a critical mass of the nonrefractory cells in the myocardium (Zipes, 1975).

It must be recognized that at any

instant in time during fibrillation myocardial cells may
be found in any phase of polarization (Figure l-2) .
Phases 0, l, 2, 3, and 4 of the cardiac action
potential, identified in the literature of cardiac electrophysiology (Vassale, 1977; Arnsdorf,

1976, Hoffman and

Cranefield, 1960), are defined as follows.

Phase 4 is the

resting membrane potential, typically -80 to -90 mV (inside

12

l

CELL

100 mV

1
CELL

CELL

CELL

8

C

D

+0,5

-0. 5·
TIME (sec)

Figure 1 - 2. Temporal dispersion of action potentials in
fibrillating myocardium. Action potentials of 4
hypothetical cells, A, B, C, and D are indicated as
functions _ of time.
During fibrillation cells may be
found in any stages of_polarization at any instant
in time. During fibrillation Phase 4 is usually
abbreviated (Cells B and C), and often excitation
may occur in the latter part of Phase 3 (Cell A) ;
•the height_of _t y ~ical action potentials in
fibrillation is about 75 mV (Sano, 1958).
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of the cell negative).

During Phase 4 small inward sodium

and outward potassium ionic currents are in balance for
working myocardial cells.

In pacemaker cells, gradual

diastolic depolarization may occur due to an imbalance in
these ionic currents.

Phase 4 is succeeded by Phase 0,

or depolarization, the rapid upstroke of the cardiac action
potential.

Phase 0 is associated with a rapid increase in

sodium conductance and inward sodium current caused by
suprathreshold stimulation of the cell, as the transmembrane
potential is caused to exceed a critical ''firing threshold"
voltage (typically -50 to -60 mV).

Phase 1 is the brief

overshoot or reversal of the transmembrane potential at
the time of maximal sodium conductance.

Phase 2, the

plateau of the cardiac action potential, has recently been
shown to be sustained by inward calcium current.

In Phase

3 potassium conductance becomes dominant and the resultant
outward potassium current leads to repolarization of the
cell and a return to Phase 4.

During Phases 0, 1, and 2 the

cell cannot be stimulated, since it is already depolarized.
This period is defined as the absolute refractory period.
During the midportion of Phase 3, the descending limb of
the action potential, the cell may be stimulated by suprathreshold stimuli and is said to be relatively refractory.
During the terminal portion of Phase 3, the cell may be
hyperirritable.

14

If fibrillation is conceived as the presence of
numerous randomly oriented wavefronts of depolarization,
spreading throughout the myocardium as represented in
Figure 1-3, then electrical defibrillation requires
simultaneous excitation of the cells just ahead of each
wavefront.

These cells would be found either in Phase 4 of

polarization or in the latter part of Phase 3.

A critical

assumption of this hypothesis is that for the purpose of
defibrillation the cells requiring the strongest stimulus
for excitation are those completely repolarized cells in
Phase 4.

A noteworthy implication of this assumption is

that it is not necessary to excite those cells in the
midportion of Phase 3, which are relatively refractory, in
order to defibrillate.

Nor is it necessary to effect

cells in Phases 0, 1, or 2.

The hypothesis assumes that it

is necessary only to depolarize one side of the cell membrane
of each cardiac muscle cell to the extent of the difference
between the resting (Phase 4) membrane potential and the
cellular firing threshold.

This stimulus would be

sufficient to excite all fully recovered cells as well as
all cells just emerging from their relative refractory
period.
The Action of Defibrillating Current
At the Cellular Level
Consider a rectangular block of ventricular myocardium
containing muscle cells, extracellular fluid, blood vessels,

15

•

..

.

VENTRICULAR SURFACE
(VENTRAL ASPECT)
Figure 1-3. Schematic representation of multiple, random
wavelets of depolarization traversing the ventricles
during fibrillation. Heads of arrows indicate the
wavefront of each wavelet and its direction of propagation.
Tails of arrows indicate length of refractory
tissue strips trailing each wavefront. ~~en a wavefront encounters a refractory strip it will split
into daughter wavelets or become extinguished.
In
sustained fibrillation successive generations of
wavelets are always able to spread into areas of
excitable myocardium.
In theory, an effective
stimulus from a defibrillator simultaneously excites
and renders refractory the tissue just ahead of
each wavefront, abolishing their propagation.
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and connective tissue.

Assume that the long axes of the

muscle cells are oriented perpendicular to the flow of
defibrillating current as would be true for most of the
circumferential ventricular fibers in open chest defibrillation (Figure l-4(a)).

Consider a very thin section of

this block of tissue lSv thick and lcm
illustrated in Figure l-4(b).

2

in surface area, as

The lSv thickness is chosen

because this is the diameter of a typical ventricular muscle
fiber.

This thin slice of tissue can be divided conceptually

into resistive and capacitive components, as shown in Figure
l-4(c).

The resistive component consists of the electrolyte

filled extracellular space which comprises about 30 percent
of the volume of mammalian ventricular muscle (Frank and
Langer, 1974).

The capacitive component consists of muscle

and connective tissue cells, about 70 percent of ventricular
volume, which are surrounded by high resistivity cell
membranes.

The cell membranes of cardiac muscle have been

modeled as parallel resistive-capacitive networks (Woodbury,
1962) , but

me~~rane

resistance is so large with respect to

the extracellular fluid resistance (2,000 ohms for lcm

2

2
versus 0.3 ohms for lcm ) that menilirane resistance can be
ignored for the present discussion and the membranes considered as purely capacitive, as shown in Figure l-4(d).
If a direct current pulse is applied to the network
depicted in Figure l-4(d), current will flow initially
onto the series capacitors, causing them to charge.

This

17

1 em -----+

(a)

·

·
(b)

(c)

Figure 1-4. Scheme for analysis of the action of defibrillating current upon myocardial cells.
(a)
Bundle of myocardial fibers oriented perpendicular
to electric current field.
(b and c) Hypothetical
tissue element 1 cm2 in cross-sectional area and
one cell diameter in thickness, containing cells
and extracellular fluid.
(d) Equivalent circuit
for hypothetical tissue element.
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charging of membrane capacitance will tend to depolarize
the ca tho::lal
the cell.

side and hyperpolarize the anodal side of

The time for membrane capacitors to charge

maximally is about five''RC"time constants; thereafter all
of the current flows through the extracellular fluid
resistance, at which time the final voltage across both
series capacitors is equal to the voltage drop across the
resistor, RE,...,..
.
.......
Values of R and C from the literature may be substituted into the equivalent circuit of Figure l-4(d)

in

order to estimate the gross electrical effects of the
passage of a

100 majcm

2

threshold pulse of defibrillating

current through the hypothetical
myocardium.

15~ x 1 cm 2 slice of

The estimate of 100 ma/cm

2

threshold current

density is derived from data on open-chest defibrillation
with electrodes of specified size,obtained recently in
our laboratories (Grubbs and Wilcox, 1975) .

This figure is

also consistent with estimates derived from published openchest threshold data (Geddes, 1970; 1974).

Membrane

capacitance of Purkinje fibers has been measured by Weidmann,
(1952) and confirmed by others (Arnsdorf and Bigger, 1975),
who obtained a value of approximately
membrane.

lO~F for lcm 2 of

These authors also determined the overall

resistivity of intracellular fluid to be approximately 100
ohm-em.

The resistivity of extracellular fluid is assumed to

be approximately that of plasma, or about 60 ohm-em.

Given
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these values, the resistances and capacitances of Figure
l-4(d) may be calculated and are indicated in Figure 1-5.
The resistance of the extracellular fluid, indicated in
Figure 4-l(c), is the product of the resistivity of the
medium and the "length" of the fluid slab in the direction
parallel to current flow, divided by the cross-sectional
area of the fluid slab: 60 ohm-em x 0.0015 cm/0.3 cm
0.3 ohm.

2

or

The final voltage to which both series membrane

capacitors are charged by a 100 ma/cm

2

defibrillating shock

is 100 rna x 0.3 ohm or 30 mV.
Charging the membrane capacitors results in hyperpolarization of the anodal side and depolarization of the
cathodal side of the typical
Figure l-5(b).

15~

diameter cell, shown in

If 30 mV potential difference is divided

equally across the series membrane capacitors, the anodal
side of the 15 micron cell is depolarized by 15 mV and the
cathodal side hyperpolarized 15 mV.

Such a change is of the

order of that necessary to bring the transmembrane potential
on the cathodal side of the cell from a resting potential to
the firing threshold.
Note that if the myocardial fibers in the hypothetical
block of tissue were oriented parallel rather than perpendicular to the direction of current f lov1, the

11

length 11

of the slab of extrafluid extracellular fluid would be
greater.

A greater final voltage difference would develop

across this distance causing correspondingly greater changes
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i

I = 100 ma

i

0.3Q

30 mV

-15~_ __,
(a)

1

(b)

Figure 1-5. Equivalent circuit for a hypothetical slice
of myocardium 1 cm2 in cross-sectional area and one
cell diameter in thickness.
(a) Approximate values
of the circuit elements.
(b)
Steady state voltage
differences caused by the passage of an electric
current of defibrillating intensity.
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in the transmembrane potential at the cathodal and anodal
ends of the cell.

Hence any shock able to stimulate

fibers oriented perpendicular to the current flow would
also be able to stimulate fibers oriented parallel to the
current flow.
Also note that the time for membrane capacitance to
charge to very near the maximal voltage is a matter of
several "RC" time constants for the myocardial cells.
the values 10 ohm-cm

2

Using

for membrane capacitance, 100 ohm-em

for intracellular fluid resistivity, and 0.0015 em for cell
length and 1 em

2

for aggregate cell surface area, the time

constant for charging of membrane capacitance is 5 x 10
sec.

-6

The time constant for voltage-dependent activation of

sodium conductance, however, is much longer, on the order
of 0.5 msec (Ehrenstein, 1976; Hodgkin and Huxley, 1952).
The passage of current through cardiac tissue via macroelectrodes rapidly changes the transmembrane potential of
cells within a few microseconds.

However, the cathodal

side of the cell must remain above the firing potential
for several milliseconds before sodium activation will
become sufficient to cause rapid sodium inrush, depolarization,
and refractoriness.
The hypothesis presented in this thesis is that the
essential requirement for defibrillation is depolarization
of one side of cardiac cells by a voltage equal to the "gap"
Er - Eth' between the resting membrane potential and the
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cellular firing threshold for a sufficient time to allow
activation of sodium conductance.

Since the amount of de-

polarization is proportional to the current density
delivered by the shock, drugs could conceivably alter the
current required for defibrillation by altering either the
firing threshold, Eth' or the resting membrane potential,

E .
r

Possible Mechanisms of Drug Action
Agents which raise the cellular firing threshold,
hyperpolarize resting cells, or both are predicted to
increase the Er-Eth gap and the current required electrical
stimulation or defibrillation of the heart.

Agents which

decrease the cellular firing threshold, hypopolarize resting
cells, or both are predicted to decrease the gap and the
current required for stimulation or defibrillation of the
heart.
The likely ways in which drugs might produce such
changes may be appreciated with reference to established
principles of cardiac membrane physiology for cells in
Phase 4 and Phase 0.
The transmembrane potential, E , is the voltage to
m
which the cell membrane capacitance is charged at any
instant in time.

E is determined by the balance of ionic
m

currents across the membrane.

Although the importance of

calcium currents in maintaining E

m

have been recently
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identified for ventricular muscle cells during Phase 2
(Beeler and Reuter, 1970; Gibbons and Fozzard, 1975), the
ions involved in Phase 4 and Phase 0 are almost exclusively
sodium and potassium for both ventricular muscle and for
nerve (Hoffman and Cranefield, 1960; Vassale, 1977).

The

net ionic current from one side of the cell membrane to
the other depends upon the membrane conductance (g) of the
ion and the electrical driving force impelling the ion.

The

driving force is defined as the difference between the
equilibrium potential for the ion (E.
) and the instantaneous
10n
membrane potential (Em).

The resultant net ionic current

may be predicted by the ohmic relationship
I .

1on

= g.1on (E m

-

E.

10n

) •

The equilibrium or reversal potential, E.
, is determined
10n
by the ratio of intracellular to extracellular concentration
of the ion by the Nernst equation
E.
1on

= RT
F

[ion] .
l
x,n[ion]
n

0

where square brackets indicate molar concentrations, and the
subscripts i and

0

denote "inside and "outside" the cell.

Evaluating the physical constants and converting to common
logarithms, the Nernst equation becomes E.
(in mV)
10n

=

61.5 log{[ion]i/[ion] }, for monovalent cations at body temp0
erature selectively permeable to the membrane.

The ionic
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conductance, g(ion), is a function of both E

and of time.
m
The time dependence of g(ion) reflects the kinetics by
which presumed ionic channels traversing the membrane open
and close following a change in E .
m

During Phase 4 and Phase 0, the membrane potential is
determined by the balance between the transmembrane sodium
current, INa' and the transmembrane potassium current, IK.
Since EN
J:

a

is positive (typically +80 mV) and greater than

Em,and since EK is negative(typically -90 mv);the sodium
current is inward, tending to depolarize the cell, and the
potassium current is outward, tending to hyperpolarize the
cell.

The gNa at the time of the transition between Phase

4 and Phase 0 is a rapidly increasing (concave upward)
function of Em; whereas gK is assumed to be approximately
constant.

More rigorous theoretical expressions for gNa

and gK of nerve-cell membranes as

functions of voltage

and time have been described elsewhere (Ehrenstein, 1976;
Hodgkin and Huxley, 1952), which indicate that there is a
measurable voltage dependent increase in gK during Phase 0.
However, compared to the very large increase in gNa during
excitation, gK remains relatively stable just before and
after the onset of Phase 0.

Only later, after Phase 0

has irrevocably begun, does potassium conductance markedly
increase (Hodgkin and Huxley, 1952).

The present discussion

is concerned only with events just before and after the
rapid sodium influx which initiates Phase 0, so it is
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reasonable as a first approximation to treat gK as a constant.*
Given the assumptions that gNa is an accelerated
function of E and that gK is essentially constant at the
m
time of excitation, the transmembrane currents involved may
be illustrated as shown in Figure l-6(a).

This figure illus-

trates hypothetical transmembrane sodium and potassium
currents, as conceived by the author, at different levels
of Em.

IK is a linear function of Em' increasing as the

membrane potential is made more positive than the potassium
equilibrium potential.

INa is an accelerated function of

Em' indicating the voltage dependent increase in gNa as
the membrane potential is made less negative.

To permit

easy comparison of the magnitudes of the ionic currents in
opposite directions across the membrane, the absolute values
of INa and IK are plotted.

The straight line for potassium

current and the curved line for sodium current intersect
at two points for which INa

= IK.

The left-hand point is

a stable equilibrium and indicates the resting membrane
potential.

The right-hand point is an unstable equilibrium

and indicates the cellular firing threshold.

This feature

of Figure l-6(a) may be appreciated by considering the
effects of hyperpolarizing and depolarizing electrical

* If

gK is considered more exactly as an increasing function
of Em with a derivative significantly less than that of the
gNa versus Em curve, the predictions of the present theory
would be qualitatively the same with only minor quantitative differences.
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Figure 1-6. Balance of inward sodium and outward potassium
currents in ventricular myocardial cells during Phase
4 and early Phase 0.
(a) Absolute values of sodium
and potassium currents are plotted as a function of
transmembrane potential, Em·
Zones 1, 2, and 3 of
the Em domain are identified. (b) Effects of alteration of Em by electrical stimuli.
If Em is transiently driven into Zone 1 or Zone 2 it will return
to the stable equilibrium value, Er.
If Em is driven
into Zone 3, an action potential will be initiated.
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stimuli which might be delivered via an intracellular
microelectrode connected to a constant current source.

The

results of such hypothetical stimulation are shown in
Figure l-6(b).

Suppose a hyperpolarizing current is used

to drive the E
(1).

more negative than E into the zone denoted
m
r
After the current is terminated, the inward sodium

current will be greater than the outward potassium current,
and the cell will depolarize until INa
membrane potential.

=

IK at the resting

If a low amplitude, depolarizing

current is delivered, driving the E into zone (2) and
m
then terminated, the outward potassium current will be
greater than the inward sodium current, again driving the
Em back toward the Er.

Such a current would constitute a

subthreshold stimulus.

However, if a stronger depolarizing

current were to drive the E into zone (3) , the inward
m
sodium current would exceed the outward potassium current,
causing further depolarization of the cell and initiating
Phase 0.
stimulus.

Such a current would constitute a suprathreshold
The right-hand intersection of the sodium and

potassium current functions, therefore, represents the
cellular firing threshold.

The voltage gap Er - Eth to

which the membrane capacitance of the cell must be charged
to initiate an action potential is represented by the
horizontal distance between the intersections of the sodium
and potassium current functions.
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Prediction of Drug Effects
Using this graphical representation of the critical
ionic currents involved in excitation of the cell, it is
easy to identify four general mechanisms by which drugs
could alter the strength of the electrical stimulus required
to excite the cell.

These include alteration of the gK,

alteration of the gNa, alteration of the EK, and alteration
of the ENa·
For example, if a drug increased gK by a factor a > 1,
the slope of the IK line in Figure l-6(a) would be increased.
As a result, Er would become slightly more negative, Eth more
positive, and the voltage gap, Er- Eth' would increase;so
that a stronger stimulus would be required to excite the
cell.

Similarly, if gNa were decreased by a factor a < 1,

the gap between Er and Eth would also increase.

If potassium

conductance were increased and sodium conductance decreased
simultaneously, then an even greater increase in the
tion threshold would occur.

stimula~

Conversely, if gK were de-

creased, gNa were increased, or both, the Er - Eth gap would
decrease together with the stimulation threshold.

These

possibilities are summarized in Table 1-1.
In addition to altering the relationship between sodium
and potassium conductance of the membrane, drugs might also
influence the stimulation threshold by directly or indirectly altering the sodium or potassium equilibrium
potentials.

Since the difference E - EN is large (about
m
a
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Table 1-1

Predicted effects on cardiac stimulation or
defibrillation threshold caused by changes in
transmembrane ionic conductances during
diastole.

gNa
decreased

normal

increased
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-160 mV) relatively large changes in ENa would be required to cause large percentage changes in I
ENa).

Na

= gNa(Em -

However, in the case of potassium, Em - EK is

relatively small (about 10 mV) .

Hence smaller changes in

the EK caused by disturbances in the ratio of local extracellular to intracellular potassium concentration could more
easily produce large percentage changes in the stimulation
threshold.

Such changes would be represented graphically

in Figure l-6(a) as a parallel shift in the potassium current
line.

For example, increased extracellular K would cause

the potassium current line to shift to the right, narrowing
the Er - Eth gap and reducing the stimulation threshold.
Summary of the Theory
The theory of defibrillation developed in this chapter
assumes that fully recovered and almost fully recovered
cells in the fibrillating heart must be brought to the
cellular firing threshold, excited, and hence rendered
refractory to achieve defibrillation.

The critical variable

in determining the strength of the stimulus required is
the voltage difference or "gap" between the firing
threshold and the minimal (resting) membrane potential of
completely recovered cells.

The magnitude of this voltage

gap is determined by the balance of inward sodium current
and outward potassium current across the cell membrane.
According to accepted principles of membrane physiology,
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the factors which affect this balance include the
potassium conductance of the membrane, the sodium conductance
of the membrane, and the equilibrium potentials for sodium
and especially for potassium.

Since all of these factors

may be altered by selected drug actions, it is highly likely
that drugs may alter the threshold for electrical ventricular
defibrillation.
Rationale
To demonstrate drug-induced alterations of the
ventricular defibrillation threshold experimentally, it is
necessary to choose a species of animal
enough to sustain fibrillation.

with hearts large

The hearts of small,

inexpensive laboratory animals, such as rats, will not
sustain fibrillation, probably because the impulse wavelength in mammalian myocardium exceeds the length of
conduction pathways in such small hearts.
In the studies to be described, the dog was selected as
the experimental animal.

These studies were carried out in

intact animals using transchest defibrillating electrodes
in order to ensure that any pharmacological effects observed were physiologically important.

Three drugs were

selected for initial study: quinidine, lidocaine, and
potassium chloride.

These agents are well known.

They

produce selective effects upon cardiac electrophysiology
in the intact animal at dose levels which do not produce
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profound systemic toxicity involving other organ systems,
and are thus appropriate for transchest defibrillation
studies.

Each produces reasonably well-characterized

alterations in either sodium conductance, potassium
conductance, or potassium equilibrium potential, and hence
is likely on a theoretical basis to influence the defibrillation threshold.
Alteration of Myocardial gNa and gK by Quinidine and
Lidocaine
The literature concerning the mechanisms of action
of antiarrhythmic drugs has been recently reviewed
(Singh, 1977; Arnsdorf, 1976; Hauswirth, 1974; Bassett and
Wit, 1973; Rosen and Hoffman, 1973).

This literature is

complicated by the study of drug action using diverse tissue
preparations, including atrial muscle, Purkinje fiber bundles, ventricular muscle, motor nerve, and squid axon;
diverse species including frog, rat, guinea pig, dog, and
human; and diverse extracellular potassium concentrations.
Direct investigation of the ionic mechanisms of antiarrhythmic drug action in cardiac muscle using preparations analogous to the voltage-clamped squid axon has been technically
difficult due to the small size and contractility of
cardiac muscle cells.

Recent applications of voltage-

clamp techniques to cardiac muscle (Beeler and Reuter, 1970;
Fozzard and Beeler, 1975) have produced promising results.
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However, this approach remains limited in cardiac muscle,
especially by capacitance-induced artifacts during the upstroke (Phase 0) of the action potential.

As a result,

conclusions about the ionic mechanisms of antiarrhythmic
drug action on excitation of cardiac muscle fibers must be
drawn from indirect evidence.
Quinidine.
Most authorities believe that quinidine acts primarily
by decreasing transmembrane sodium conductance.

Virtually

all investigators since Weidmann (1955) have found that
quinidine decreases the rate of rise of Phase 0 of the action
potential (dV/dt)

0

recorded with intracellular electrodes.

This effect is associated with a decreased slope and increased
duration

of the QRS complex of the electrocardiogram, which

is readily demonstrated in the experimental animal and in
human patients (Gettes, 1962; Prinzmetal, 1970; Heissenbuttel
and Bigger, 1970).

Such a correlation of changes in (dV/dt)

0

and the QRS complex are predicted by the interference theory
of electrocardiography (Geddes and Baker, 1975)*.

These

quinidine-induced changes are antagonized by hyperpolarization
(Weidmann,l955;Hoffman and Cranefield,l960)which would increase inward sodium current in the presence of depressed
gNa, as predicted by the expression IN

* The

a

= gNa(E m - EN a ) .

interference theory states that the electrocardiogram
(ECG) is derived from the instantaneous difference between
the excursion in transmembrane potential of two adjacent
areas of myocardium which are activated sequentially by the
same wavefront of depolarization. For example, in mammals
the subendocardial tissue of the ventricles is first
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Quinidine elevates the cellular firing threshold as measured
with intracellular electrodes (Weidmann, 1955; Yeh, 1976).
The major effect of quinidine is thus usually attributed to
decreased sodium conductance of the membrane.

At higher

concentrations of quinidine, secondary effects attributable
to decreased potassium conductance occur.

These include

prolongation of the action potential duration, refractory
period, and QT interval of the electrocardiogram (Rosen
and Hoffman, 1970; Heissenbuttel and Bigger, 1970).
Depression of both sodium and potassium conductance by
quinidine to a roughly equal degree has been demonstrated
by direct measurements of ionic currents in voltage-clamped
squid axons (Yeh, 1976).
and
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However, McCall (1976), using
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K

Na radioisotope tracer techniques in cultured human

heart cells, found that the percent decrease in the
calculated sodium permeability coefficient (pNa) of the cell
activated by Purkinje fibers. A wavefront of depolarization
then spreads to the subepicardial fibers which are activated
a time, 6t, later; where 6t is the propagation time required
for depolarization to spread from the subendocardial to the
subepicardial fibers.
The time 6t is related to the propagation velocity, c, of the wavefront of depolarization and the
distance, 6x, between the sequentially activated areas of
myocardium by the expression 6t=6x/c. According to the
interference theory, the ECG amplitude is proportional to
the instantaneous difference in transmembrane potential, 6V,
between these two areas of tissue.
It follows that
6x
c
Noting that the propagation time, 6t, is small compared to
the action potential duration, and passing to the derivative,
6x
c

( 1)

35

membranes was approximately twice the percent decrease in
calculated potassium permeability coefficients of the cell
membranes after exposure to 10

-6

to 10

-3

·molar quinidine.

Assuming that quinidine acts by decreasing transmembrane sodium conductance greater than potassium conductance, one may predict its effect on defibrillation threshold.
On the basis of the theoretical analysis summarized in
Figure l-6(a) one would expect quinidine to shift the sodium
current curve downward and to the right.

Such a shift

would slightly lower the resting membrane potential and
raise the cellular firing threshold.

The resultant increased

"gap" between these two equilibrium voltages would, in
theory, cause an increase in the stimulation or defibrillation
threshold.

The same net effect on the gap voltage would be

expected if the sodium conductance were decreased by a factor
greater than that for potassium conductance.

Thus the electrocardiographic signal is directly proportional
to the derivative of the cellular transmembrane potential
and the distance between the sequentially activated areas
of myocardium (in this case ventricular wall thickness) and
inversely proportional to propagation velocity. For
example, in left ventricular hypertrophy, the amplitude of
the QRS complex is greater than normal due to increased
ventricular wall thickness, 6x, in accordance with equation
(1). The amplitude of premature ventricular contractions
in the ECG may be greater than normally conducted beats
because the distance between sequentially activated areas
of muscle, 6x, is larger and because the effective propagation velocity, c, is smaller due to bypass of Purkinje
fibers penetrating the ventricular wall.
Assuming that the major electrophysiologic effect of
quinidine at the cellular level is to decrease (dV/dt)
0
and prolong Phase 0, without altering the final amplitude of
the action potential, the interference theory predicts two

36

Lidocaine.
Lidocaine appears to act by increasing transmembrane
potassium conductance, probably to a greater degree in
Purkinje fibers than in working myocardial cells (Davis and
Temte, 1969; Arnsdorf and Bigger, 1972).

In therapeutic

concentrations, lidocaine, unlike quinidine, has little
effect on (dV/dt)

0

(Davis and Temte, 1969; Bigger and

Mandel, 1970), indicating that blockade of sodium conductance
is not the most important mechanism of lidocaine action.
Positive physiological correlates of lidocaine action
include decreased rate of Phase 4 diastolic depolarization
of pacemaker cells (Davis and Temte, 1969; Bigger and Mandel,
1970), which has been attributed to a progressively decreasing potassium conductance (Trautwein, 1973).

Increased

potassium conductance during Phase 4 in response to lidocaine

changes in the QRS complex of the electrocardiogram. The
first is a decrease in the amplitude of the QRS complex
due to decreased dV/dt. The second is an increase in
the duration of the QRS complex, since dV/dt will remain
positive for the longer time required for complete depolarization.
(Both of these effects occurred in
the quinidine studies reported in Chapter 3) . The
first effect may be antagonized by the concomitant
decrease in conduction velocity produced by quinidine,
since propagation velocity appears in the denominator
of equation (1). Hence the second effect, prolongation
of the QRS complex, is a more reliable sign of quinidine
effect in the electrocardiogram.
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would thus explain this aspect of its antiarrhythmic
action.

Lidocaine also may decrease the action potential

duration and refractory period of cardiac cells, a phenomenon
consistent with increased potassium conductance during
Phase 3 repolarization (Mandel and Bigger, 1971).

In

Purkinje fibers depolarized by injury, exposure to lidocaine may cause a return of the resting membrane potential
toward normal (Arnsdorf and Bigger, 1972).

This phenomenon

is consistent with the expectation that increased potassium
conductance, gK, would cause a greater stabilizing current,
IK

=

gK(Em - EK), when Em is farther from the EK in de-

polarized cells.

Recently Arnsdorf and Bigger (1975), using

multiple microelectrodes and cable theory applied to long
cardiac Purkinje fibers, have measured a 64 percent increase
in membrane potassium conductance after exposure to
therapeutic concentrations (5 mg/1) of lidocaine.

Kabela has

.
.
d 42 K e ffl ux f rom d og h eart t1ssues
repor t e d 1ncrease
a f ter
exposure to lidocaine.

This body of evidence strongly

suggests increased potassium conductance as the therapeutic
mechanism of lidocaine action upon the heart.
At higher concentrations, or in the presence of higher
extracellular potassium levels (Singh and Vaughan Williams,
1971), lidocaine begins to exert "quinidine-like" effects.
These include decreased amplitude, decreased rate of rise
and prolonged duration of the action potential (Mandel and
Bigger, 1971), and are attributable to decreased sodium
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conductance.

This quinidine-like action at higher con-

centrations has been proposed as the principle local
anesthetic mechanism of procaine and lidocaine in peripheral
nerves (deJong, 1970).
The analysis of Figure l-6(a) predicts that lidocaine
would increase stimulation and defibrillation threshold
by raising the potassium current line and, at higher
doses, lowering the sodium current curve.

These shifts

would widen the voltage gap between the equilibrium points
for the resting membrane potential and the cellular firing
potential,and~proportionally

increase the current required

for stimulation or defibrillation.
Alteration of EK by Potassium
The dependence of the potassium equilibrium potential,
EK' and resting membrane potential, Em' upon the ratio of
intracellular to extracellular potassium concentration
(K./K )*has been well described by Hoffman and Cranefield
~

0

(1960) and recently reinvestigated in terms of ionic
activities by Miura (1977).

These reports clearly indicate

that the equilibrium potential for potassium is very
sensitive to changes in K .
0

This result may be appreciated

by differentiating the Nernst equation

* In

this and the following discussions, square brackets
denoting molar concentrations of ions are omitted for
simplicity of notation.
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K.

=

EK

first with respect to K

0

=

+26.7
K

1

-61.5 log K

and

0

0

and then with respect to K :
l

d (EK)
dK.
l

=

-26.7
K.

so that

l

K.

=

l

K

:::: 20-40

0

Hence the transmembrane potential is normally 20-40 times
more sensitive to changes in K

0

than to changes in K ..
l

Small changes in extracellular potassium concentration may
cause large changes in the potassium equilibrium potential
and in turn the threshold current for defibrillation.
Mathematical Feasibility of Varyihg K0 and Calculated EK
While Keeping Ki Essentially Constant.
Because measurement of intracellular potassium
concentrations in the myocardium requires sacrifice of the
experimental animal, it is desirable to keep K. levels
l

essentially constant during the course of an experiment.
Then a single determination of myocardial K. at the end of
l

the experiment may be interpreted with some validity.

As

illustrated in Figure 1-7, the overwhelming majority of
total body potassium (about 50 mEq/kg body weight) is found
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Figure 1-7. Approximate normal distribution of potassium
ions in body fluid compartments. TBW = total body
water, ECF = extracellular fluid, ICF = intracellular fluid.
Roughly 98 percent of total body
potassium is contained within cells.
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intracellularly, whereas only about 1 mEq/kg is found in
the extracellular fluid.

If 1.0 mEq/kg of potassium is

infused intravenously over 3-5 minutes, K

0

will increase

roughly 4 mEq/1 -- enough to double normal plasma levels.
In practice, the intravenous dose of 1.0 mEq/kg produces
about a 3.5 mEq/1 rise in plasma potassium levels in our
laboratory.

However, even if this entire potassium dose

enters the cells, K. will be changed by only 2 percent.
l

Thus it is possible to significantly raise K

0

by potassium

infusion while keeping K. essentially constant.
l

A "bolus plus infusion'' dosage schedule permits repeated determination of the defibrillation threshold at a
specified K

0

level.

The mathematical rationale for the use

of a combined bolus plus infusion dosage schedule to
produce a ''square" step-up in the plasma levels of a drug
was described by Wagner (1974).

Using this technique in

dogs with bilateral ureteral ligation to prevent renal
excretion, the maintenance of a stable elevation in K

0

for

100 minutes requires the administration of 2.0 mEq/kg KCl.
This total dose represents a
body potassium.

4 percent increase in total

Since plasma levels remain constant from

the beginning to the end of the 100 minute period, about
half the total dose of 2 mEq/kg must be transported into
cells during 100 minutes of infusion.

As a consequence,

overall intracellular potassium levels increase by
approximately 1 mEq/kg, or only about 2 percent at the end
of 100 minutes.
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Measurement of Intracellular Potassium Concentration.
Because it is physically impossible to separate the
intracellular and extracellular fluid compartments of solid
tissues, intracellular potassium concentration must be
calculated indirectly.

The calculation can be made from

measurements of total tissue and extracellular potassium
concentrations on the basis of the following relation:

= 0 0 K0 + 0.K.
; where
1 1

Kt

Kt

= overall potassium concentration of myocardial tissue

0

= volume fraction of the extracellular space

0

0.

1

= volume fraction of the intracellular space = (l-0 0 ) for

heart muscle.

The intracellular potassium concentration is

calculated as
Kt K.

1

1-

0.

0

0

K0

0

provided 0 , the volume fraction of the extracellular space
0

is known.

Classically 0

o

is measured as the volumeo:f distribu-

tion of an indicator substance which is permeable to
capillaries but which is excluded from cells.
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Na,

thiosulfate, and manitol have been used as indicators for
this purpose (Welt, 1970).

The method developed by the

author for the present studies employs nonisotopic sodium
as the indicator substance.

The sodium indicator is

subtracted rather than added to the extracellular space as
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the myocardium is perfused with two different isotonic
solutions, the first (lactated Ringer's solution) containing
physiologic sodium concentration and the second (5 percent
dextrose in water) containing zero sodium concentration.
Tissue samples are analyzed for total sodium and potassium
content by flame photometry after each perfusion.

Calcula-

tions are made as described in Chapter 3.
In this manner it is feasible to study defibrillation
threshold as a function of EK, by using a regulated KCl
infusion to alter the K /K. ratio.
0

K

l

0

may be determined

from samples of blood plasma, and K. may be measured
l

terminally in the same animal with confidence that it has
remained essentially constant during the experiment.
With knowledge of both K

0

and Ki, EK may be calculated from

the Nernst equation and related to defibrillation threshold.

Importance of the Stability of the Animal Model
Before undertaking the drug studies, however, certain
critical questions concerning the validity and the stability
of the animal model must be addressed.

These questions

concern the effect of anesthesia and the reproducibility
of control data obtained when no drug other than the
anesthetic is administered.

Attention to these questions,

as described in Chapter 2, ensured that presumed effects of
cardiac drugs on the defibrillation threshold would be
correctly interpreted.
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Objectives of the Investigation
According to the preceding rationale, the objectives
of the investigation described in this thesis were as
follows:
e

To determine the effects of the induction of pentobarbital anesthesia on ventricular defibrillation
threshold.

e

To determine the stability and precision of control
defibrillation threshold data in pentobarbital
anesthetized dogs.

e

To determine the Affect of intravenous quinidine
gluconate on ventricular defibrillation threshold.

e

To determine the effect of intravenous lidocaine on
ventricular defibrillation threshold.

e

To determine the effect of elevated extracellular
potassium concentration and potassium equilibrium
potential on ventricular defibrillation threshold.

e

To compare observed drug effects with theoretical
predictions.
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CHAPTER 2
EVALUATION OF THE ANIMAL MODEL FOR
PHA~ACOLOGIC

STUDIES

Pentobarbital Anesthesia
All controlled experimental studies of electrical
ventricular defibrillation reported to date have used
anesthetized animals as subjects
anesthetized dogs.

in most cases barbiturate

In contrast, virtually all clinical

ventricular defibrillation outside the operating room is
carried out in unanesthetized patients in settings such as
the coronary care unit or emergency room.

Recently the

barbiturate anesthetized dog has been criticized as a model
of normal cardiovascular physiology(Priano,l969). Since no study
can be found in the literature reporting the influence of
anesthesia on the efficacy of electrical defibrillation,
a reasonable question may be raised about the validity of
anesthetized animal models used for defibrillation studies.
Unquestionably, anesthetic agents of all kinds have
direct effects upon excitable biologic membranes.

Although

the central nervous system is the most important site of
action of general anesthetic agentsi many anesthetics,
including pentobarbital, are known to affect the mechanical
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and electrical performance of cardiac muscle.

The amplitude

and strength of myocardial contraction are depressed by
cyclopropane, diethyl ether, nitrous oxide, and halothane,
as well as by barbiturates including pentobarbital, secobarbital, and thiopental (Price, 1955; Flacke, 1962;
Hardman, 1959; Effendi, 1973; and Etsten, 1955).

Hydro-

carbon anesthetics may depress the rate of the sinus node
pacemaker as well as the speed of atrioventricular and intraventricular conduction (Flacke, 1962; Hardman, 1959; Effendi,
1973; Etsten, 1955; Smith, 1962).

Significant differences in

the response of the dog heart to the atrioventricular blocking and arrhythmogenic actions of digitalis glycosides have
been reported for animals anesthetized with pentobarbital
versus halothane, versus methoxyflurane (Morrow, 1972).
Cyclopropane, halothane, and to a lesser extent, thiopental,
are known to sensitize the myocardium to the arrhythmogenic
effects of epinephrine (Dressel, 1964).

Thus, it is quite

conceivable that anesthetics could alter those parameters of
cardiac electrophysiology which determine the success or
failure of electrical defibrillation.
Accordingly, the following study was undertaken to determine if the induction of anesthesia with intravenous pentobarbital sodium in the dog alters transchest defibrillation
threshold.

In this study, threshold was determined in the

same animals in both the awake, unanesthetized state and
after the induction of various levels of pentobarbital
anesthesia.
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Method
Five dogs of mixed breed, weighing 6 to 14 kg
served as subjects.

Initially each dog was anesthetized

with injectable pentobarbital sodium (NembutalR,

50 mg/ml

10% alcohol, 40% propylene glycol vehicle, 25-30 mg/kg i.v.).
No preanesthetic medication was given.

A bipolar catheter

electrode was placed in the right ventricle of the heart
via a right jugular venous cut-down, using sterile technique.
Position of the catheter electrode within the heart was
verified by recording the catheter tip electrogram and
comparing its timing with the electrocardiogram (ECG) Lead
II.

The catheter was stabilized in the jugular vein and

the wound closed with 2-0 silk sutures.

The external

portion of the catheter was protected with an adhesive elastic
bandage placed around the neck and a soft collar 8 em in
width.

After a recovery period of 36-72 hours, the de-

fibrillation threshold was determined before and after
induction of anesthesia with pentobarbital.

These investiga-

tions in unanesthetized and anesthetized subjects were
carried out in accordance with National Institutes of Health
and institutional guidelines for the use of laboratory
animals (''Guide", 1972; "Regulations", 1972).
Defibrillation threshold in awake, unrestrained animals
was measured as follows: ECG Lead II electrodes were applied
to the limbs and the position of the catheter electrode was
confirmed by recording the catheter tip electrogram.
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Defibrillating electrodes, held in position with rubber
straps, were applied to the shaved skin of the thorax with
electrolytic jelly, one centered over the apex beat area
and the other in the opposite position on the right chest
wall.

The defibrillating electrodes were stainless steel

discs, 2 mm thick and 8-10 em in diameter (20 percent of the
animal's chest circumference + lcm).

The standard location

of each electrode was outlined in ink on the thorax.
Ventricular fibrillation was produced by the application of a 1 sec train of 60 Hz, 2 msec duration rectangular
electrical pulses of 5-15 volts intensity via the right
ventricular catheter.

Ventricular fibrillation was con-

firmed by the presence of random waves in the electrocardiogram and by the descending level of consciousness of
the subject.

As the animal lost consciousness, it was

placed in dorsal recombency.
The defibrillator employed contained a 16

~F

capa-

citance,a 44 millihenry inductance, and a 7 ohm internal
resistance in series with the subject.

A 1.00 ohm, 100 watt

resistor in series with one electrode was used for measuring
current output.

The peak output voltage of the defibrilla-

tor could be varied continuously from 0 to 8000 volts.
The duration of the delivered current pulse, slightly
dependent upon subject resistance, was typically 4-5 msec.
The waveform of the current pulse was a heavily damped
sinusoid.
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As soon as possible after the confirmation of ventricular fibrillation (15-45 sec after endocardial stimulation), a defibrillator shock, calculated to be adequate
for defibrillation on the basis of the dog's body weight
as described by Geddes (1974), was delivered at the time of
end-expiration.

The voltage and current applied to the

subject were measured using a Tektronics model D-11 dual
channel storage oscilloscope.

Defibrillation was con-

firmed by palpation of the femoral pulse and QRS complexes
in the electrocardiogram.

With return of consciousness, the

animal was allowed to right itself.

After a recovery

period of about 2 min, the animal was refibrillated and
defibrillation was attempted with a voltage setting 5-10
percent less than that of the previous trial.

This

procedure was repeated until the animal was not defibrillated by the first shock, and then a stronger shock
was applied immediately to restore cardiac pumping action.
Threshold voltage and current were defined as the lowest
values able to defibrillate the ventricles.

Only data

from the first shock delivered after the onset of
fibrillation were used in calculation of threshold.

In

this study threshold values were considered adequately precise if they differed no more than 10 percent from values
unable to defibrillate the ventricles.

Delivered energy

and charge were calculated as described by Babbs and
Whistler (1978).
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Twenty minutes after the defibrillation threshold was
determined in the unanesthetized animal, intravenous pentobarbital sodium (25-30 mg/kg), was given to produce
surgical anesthesia and the defibrillation threshold
measurement was repeated with the animal in dorsal recumbency.

After a three-day recovery period, another set of

threshold determinations was made in the awake and
anesthetized states.
On the final day of testing the defibrillation threshold
was determined following larger doses of pentobarbital.
After the routine threshold determination under surgical
anesthesia, sufficient intravenous pentobarbital was given to
produce apnea and the threshold measurement repeated.

Then

sufficient intravenous pentobarbital was given to produce
circulatory shock (defined as systolic blood pressure less
than 50 mmHg measured via a catheter placed in the abdominal
aorta) and a final threshold determination made within 10
minutes.

During apnea and shock the animal was maintained

using mechanical ventilation sufficient to produce a
respiratory minute volume, measured with a Wright
respirometer, roughly equal to that measured under surgical
anesthesia.
Results
In all 5 dogs comparisons could be made between
defibrillation thresholds in the awake and the anesthetized
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states.

In one dog, three successive comparisons of

awake versus anesthetized threshold values were made during
a twelve-day period.

Threshold current data for this animal

are plotted in Figure 2-1.

The ratios of the threshold peak

current for all dogs at all levels of anesthesia to the
average threshold under surgical anesthesia for each animal
are plotted in Figure 2-2.

No consistent effect of pento-

barbital anesthesia on the ventricular defibrillation
threshold is evident.

The slight

do~vnward

trend in Figure

2-2 is not statistically significant.
Mean values of threshold shock strength, in terms of
peak current,

and delivered energy per

kilogram body weight, are given in Table 2-1.

One-way

analyses of variance indicate that the observed effects of
anesthesia level upon threshold current,

and energy

are far from statistically significant, as indicated by
the p values in the table.
The response of unanesthetized dogs to the fibrillationdefibrillation procedure is worthy of mention.

Typically,

the dogs were not alarmed by the intracardiac electrical
stimulation used to induce fibrillation.

The loss of

cerebral blood flow due to ventricular fibrillation produced
initial excitation, lasting 5-15 sec, which rapidly
diminished as the animal lost consciousness.

Delivery of

defibrillating current caused a brief, forceful contraction
of thoracic and abdominal musculature, resulting in
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Figure 2-1. Threshold peak current for ventricular defibrillation in unanesthetized and anesthetized
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the unanesthetized animal was greater than, equal
to, and less than the threshold current after
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Table 2-1.

Mean Defibrillation Threshold* at 4 Levels of Anesthesia
Awake

Surgical
Anesthesia

Apnea

Shock

F

p

Ratio

Value

Peak Current
(amps/kg)

1.25+.28

1.22+.17

1.21+.18

1.13+.21

0.21

0.89

Delivered
Energy
(joules/kg)

1.55+.77

1.35+.46

1.28+.42

1.11+.17

0.51

0.68

Number of
Observations

*+

7

11

4

3

1 S.D.

Ul
~
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vocalization.

Animals for whom the total circulatory arrest

time was less than 30 sec rapidly regained consciousness,
and resumed a sitting or standing position.

Animals for

whom the total circulatory arrest time was 30-60 sec did not
regain consciousness as soon after defibrillation.

These

animals remained in dorsal recombency after resuscitation and
appeared dazed or tranquilized.
Conclusion
The data indicate that defibrillation threshold is
negligibly affected by the induction of anesthesia with
pentobarbital sodium.

Hence this anesthetic was selected

for use in further defibrillation studies.
Stabilitv and Precision of Control Data
The question of the stability and reproducibility of
control data is especially pertinent because of the intrinsic
nature of the defibrillation studies in which the experimental
animal literally is rescued from impending death on repeated
occasions.

Each fibrillation-defibrillation sequence rep-

resents a stress to the animal subject, including transient
circulatory arrest, possible tissue hypoxia and acidosis,
and the electric shock itself, any of which might effect
the measured defibrillation threshold.
Accordingly, the following studies were undertaken to
determine (l) to what extent defibrillation threshold is
stable and reproducible with time in pentobarbital
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anesthetized dogs and (2) to what extent the stability of
the baseline threshold level is dependent upon the recovery
interval between threshold measurements.
Method
Fifteen mongrel dogs of both sexes, weighing 4 to 16 kg
and anesthetized with pentobarbital sodium (30 mg/kg, i.v.),
served as subjects.

No other drugs except 0.9 percent saline

were administered at any time.

The trachea of each dog was

intubated and the animal placed in dorsal recumbency for
the duration of the study.

The urinary bladder was

catheterized with a #8 French filiform catheter connected
to a closed volumetric drainage bottle.

Aortic blood

pressure was recorded using a P23DB Statham transducer.
Respiratory minute volume was measured with a Wright
respirometer.

Arterial blood pH, pco , and po were
2
2

monitored using an Instrumentation Laboratories Model 213
blood-gas analyzer.

Disk electrodes, 8, lO,or 12 em in

diameter were applied to the shaved skin of the right and
left hemithoraces with electrolytic jelly and sutured in
place.

The diameter of the electrodes was standardized to

20 percent of the chest circumference, measured at the
mid-sternal level.

One electrode was centered over the

apex beat area and the other at a corresponding position
on the right chest wall, 3 em cephalad of the left
electrode.
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Mean aortic blood pressure, respiratory minute volume,
urine output, arterial blood gases, and esophageal temperature were recorded at half hour intervals.

A stable level

of surgical anesthesia was maintained in each animal by
intravenous doses of pentobarbital sodium 2-5 mg/kg each
hour.

Saline solution,0.9 percent, was given at a rate of

1-2 ml/kg/hr by vein to maintain hydration.

Esophageal

temperature was maintained in the range of 36-39°C with the
aid of warm overhead lights.
Ventricular fibrillation was initiated by 2-10 volt
60 Hz electrical stimulation of the right ventricle
delivered via a bipolar electrode catheter inserted through
the right jugular vein.

The position of the electrode

catheter in the right ventricle had been previously
verified by recording the cardiac electrogram from the
catheter electrodes.

Ventricular fibrillation was confirmed

by replacement of the QRS-T complexes of the electrocardiogram with random waves and the fall of aortic blood
pressure toward zero.
The output circuit of the damped sine wave defibrillator employed contained a capacitance of 16

~F,

an inductance

of 44 mH, and an internal resistance of 7 ohms, as determined
by the method of Babbs and Whistler(l978). The voltage on
the capacitor could be varied continuously from 0 to 8000
volts.

The maximum stored energy available was 512 joules.

A 1.00 ohm, 100 watt resistor in series with one electrode
was used for measuring the current.
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In a typical trial a defibrillator shock calculated
to be adequate for defibrillation on the basis of the dog's
body weight was delivered at the time of end-expiration,
less than 15 sec after the onset of fibrillation.

The

voltage across the electrodes and current passing through the
subject were recorded on a Tektronix model D-11 dual-channel
storage oscilloscope.

Defibrillation was confirmed by re-

turn of pulsatile blood pressure and QRS complexes in the
electrocardiogram.

After restoration of aortic blood

pressure to a stable level, the animal was refibrillated
and defibrillation was attempted with a voltage setting
approximately 10 percent less than that of the previous
trial.

This procedure was repeated until defibrillation

was not achieved, whereupon a stronger shock was applied
immediately to restore cardiac pumping action.

At no

time did fibrillation persist for more than 30 sec.
Threshold voltage and current were defined as the
lowest values able to defibrillate the ventricles.

In this

study threshold values were considered adequately precise
if peak current differed no more than 10 percent from a
value unable to defibrillate the ventricles.

Only data

from the first shock delivered after the onset of fibrillation were used in calculations of threshold.

Delivered energy

was calculated as described previously (Babbs and v7histler, 19 78) .
Three series of five dogs were studied.
threshold was measured every hour for 8 hours.

In Series l,
In Series 2,

59

threshold was measured every 15 min for 5 hours.

In Series

3, threshold was measured every 5 min for 1 hour.

This

last series represents the closest spacing of threshold
measurements consistently possible when only first-shock
data are acceptable.
Results
The stability of ventricular defibrillation threshold is
demonstrated by Figures 2-3 and 2-4, which present mean
threshold current and energy ratios as a function of time,
for animals in all three series.

The threshold current

and energy ratios were calculated by dividing the individual
threshold values by the average of the first three "baseline"
threshold values obtained for each animal.

Hence the

threshold energy and current ratios may be interpreted as
the relative values obtained in experiments in which each
animal served as its own control.
Threshold peak current remained stable in all three
series.

Decreasing the recovery interval between threshold

measurements from 60 to 15 to 5 minutes did not cause a
discernible upward or dO"ivnward drift of threshold current.
Threshold current stability was further assessed by
computing the linear regression function relating the
threshold current dose to time for each animal.

The slopes

of the regression lines so obtained give sensitive
estimates of the overall rate of change of threshold current
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Figure 2-3. Stability of defibrillation threshold current.
Data points represent mean values of the threshold
current ratio for the 5 dogs in each series at
various times after the first fibrillation-defibrillation trial. Average baseline values of threshold
current (1.00 on the vertical axis) were 1.40
amp/kg for Series 1, threshold interval = 60 min;
1.10 amp/kg for Series 2, threshold interval= 15
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= 5 min. The baseline values are not statistically
different (F = 2.49, p = 0.12). The time scale is
logarithmic.
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Stability of defibrillation threshold energy.
Data points indicate mean values of the threshold
energy ratio for the 5 dogs in each series at
various times after the first fibrillation-defibrillation trial. Average baseline values of threshold
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interval = 5 min. The values are not statistically
different (F = 2.34, p = 0.14). The time scale is
logarithmic.
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with time.

The slopes were positive for 7 of 15 dogs,

negative for 8 of 15 dogs, and not significantly different
from zero (mean slope -0.008 amp/kg/hr, n=lS, Student's
t=0.69, p=O.SO).
Threshold delivered energy data were more variable
than the current data and appeared to drift slightly downward during the first hour.

In all three series, defibrilla-

tion threshold energy after one hour was about 10 percent
less than the initial threshold energy.

The observed

decrease in threshold energy was associated with a corresponding decrease in transchest electrical impedence, calculated by dividing peak voltage by peak current (Figure
2-5) .
Arterial blood pH, pco , and po remained stable in
2
2
all control series, averaging 7.38, 34 mmHg, and 72 mmHg
respectively.

To evaluate subtle changes in blood-gas values

during the course of experimentation, linear regression
functions relating pH, pco , and po values to time were
2
2
computed for each animal.

The mean regression co-

efficients for each series are presented in Table 2-2.
One-way analyses of variance reveal no significant differences in the regression coefficients for the three experimental
groups, indicating that increasing the frequency of
threshold measurements from 1 to 12 per hour did not cause
a deterioration in arterial blood gas status.

The observed

rates of change in arterial blood pH, pco , and po ,
2
2
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of transchest impedance, z, at various times after 0
the first fibrillation-defibrillation trial to the
initial impedance value, Z0 , at time zero. The
apparent impedance Z, in ohms between the defibrillating electrodes was calculated as peak voltage/peak
current for shocks delivered at the time of end
expiration. Absolute values of Z0 for the three
series of dogs were 57 ohms for Series 1~ 60 ohms
for Series 2; and 52 ohms for Series 3. These
values are not statistically different (F = 0.72,
p

=

0.51).

Table 2-2.

Linear regression analysis of the stability of arterial blood gas data.
Regression coefficients a 0 and al of equations of best fit of the form
y=a 0 +a1t are presented as ''initial" values and "rate of change" for
blood gas variables y=pH, pC02, or p02 as a function of time, t.
Coefficients a 0 and a1 were computed for each animal. Table entries
represent the mean values of the coefficients for the animals in each
series.
The F ratios for one-way analyses of variance and associated p values
test the null hypotheses that the coefficients for the three series
are the same. The Student's t statistics and associated p values test
the null hypotheses that the mean values of the regression coefficients
a1 are zero for the population of all 15 animals. The regression coefficients for the three series are not significantly different, and the
coefficients, a , are not significantly different from zero.
1

l

Threshold
Interval
(min)

Series

I

pH
Initial Rate of _
1
Change(hr )

I

'

~rand
ean

Rate of
Change
(mmHg/hr)

60

7.37

-0.003

35

-0.2

2

15

7.38

0.006

34

0.1

3

5

7.39

-0.03

34

7.38

-0.007

34

0.31

3.27

0.04

0.74

0.09

0.96

p

I

!Student' sl

p

I
I

-6.3

I

-1.8
2.40

'

0.15
-1.26

-1.29

I

t
'

p02
Initial ~
(mmHg)

1

F

I

pco
2
Initial' Rate of
(mmHg)
Change
(mmHg/hr)

0.22

I

l

I
0.98

I.

.

I

I

0'\
,J::.

0.24
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indicated by the slopes of the linear regression functions,
were not statistically different from zero.
The precision of defibrillation threshold data may be
appreciated with reference to Figure 2-6, which illustrates the frequency distributions of the 209 threshold
energy and current ratios obtained in all three series.

The

distributions of the three series were pooled since all
have means of 0.97-0.99 and variances which are not significantly different (Bartlett's X
current; Bartlett's x2

= 2

o

2

= 0.20, p = 0.90 for

841 p = 0.24 for energy).

These

histograms illustrate the relative dispersion of threshold
data about the baseline established for each animal at the
beginning of each experiment.

The standard deviations of

the distributions are a measure of the reproducibility of
the threshold data.

Under control conditions the precision

of threshold current data is greater than the precision of
threshold energy data.
Discussion
In the absence of pharmacologic or pathologic intervention, the threshold current for ventricular defibrillation remains stable in pentobarbital anesthetized dogs.
Even though the animal is repeatedly rescued from impending
death, there appears to be no cumulative influence of repeated trials of fibrillation and defibrillation upon the
threshold current, provided no more than 30 sec of
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Figure 2-6. Histograms of threshold current and energy
ratios obtained in 15 control dogs. The width of
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fibrillation

is permitted on any trial.

This conclusion

is valid even if threshold is measured as frequently as
every five min, under which circumstances there is loss of
pulsatile blood pressure for 10-20 percent of the elapsed
time.

This stability in threshold current is associated

with comparable stability in the arterial blood pH, pco ,
2
and po .
2
The approximate 10 percent decrease in threshold
delivered energy during the first hour of testing is
associated with a corresponding decrease of the apparent
impedance between the defibrillating electrodes.

Geddes

(1975) and Chambers (1978) have reported similar decreases
in transthoracic impedance during successive ventricular
defibrillation trials in animals and in man.

These reports

imply that the critical variable associated with decreasing
impedance is the number of fibrillation-defibrillation
trials.

In our studies, however, time appears to be a

better predictor of subject impedance than trial number.
The decrease in transchest impedance during the first hour
of testing averaged 4.64 ohms/hour for the dogs of Series
1 and 5.21 ohms/hour for the dogs of Series 3.

These

values are not statistically different (Student's t = -0.28,
p = 0.79) even though threshold was obtained 12 times in
Series 3 and only 2 times in Series 1.

Accordingly factors

other than the number of fibrillation-defibrillation
trials, such as impregnation of high resistivity skin with
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electrolytic jelly, may be responsible for the slight initial
fall in transchest impedance and threshold energy.
Using the method described in this thesis, defibrillation threshold current may be measured with a precision of
~

10.9 percent of the mean, as indicated by the standard

deviation of a large population of repeated threshold
measurements in stable animal preparations.
precision of threshold energy measurements
of the mean.

The comparable
is~

21.8 percent

The two-fold greater uncertainty in threshold

energy is a direct result of the fact that delivered energy
is proportional to the square of the peak current.

As

reported in detail elsewhere (Babbs and Whistler, 1978),
the energy, W, delivered by a damped sine wave defibrillator
may be calculated from the peak current, I, by an expression
of the form N

=

2
ai , where the factor, a, contains terms

relating to the internal resistance, inductance, and
capacitance of the defibrillator and the transchest impedance
of the subject.

Hm...,ever, if"a"is taken as a simple

constant, all of the observed variance in threshold energy,

W, may be explained.

Consider Gaussian random variable, I

with mean value, mi, and standard deviation
for any constant, a, then

0

ow

~

02
I

mi

=

2

I

2

mi
2

oi

-z·

mi

+ 1

+ 4

0

I

•

If W

1

= ai 2
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For the special case cri;mi << 1, indicating relatively
small variations in I,

crw/~~

z2cri/mi.

If I is taken as

the threshold current ratio in defibrillation experiments
one would therefore expect

ow row

2 0.107
0.984

The observed uncertainty,
ratio was 0.218.

= 0.217

crw/~,

in the threshold energy

Thus the greater uncertainty of threshold

energy, compared to threshold current, may be explained by
the necessary mathematical relationship between energy and
current.

The slight decrease in transchest impedance which

was observed does not contribute significantly to the
variability in threshold energy data.
One additional factor which may be quantitated at this
time contributes to the variability in defibrillation
threshold data.

Some of the variability in measured

threshold values is due to the method of threshold determination in which discrete current values differing by
approximately 10 percent are tested, rather than due to
variation in the animal's true threshold.

In a discussion

of the precision of defibrillation threshold data, it is
worthwhile to identify the magnitude of this sampling variance
in order to assess how much of the observed variance in
threshold data is due to the experimental animal and how
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much of the observed variance is due to the experimental
protocol.
Suppose the true, physiologic value of the defibrillation threshold current remained absolutely constant at a
value I

and that the distribution of measured thresholds

0

shown in Figure 2-7 is uniform within the interval I
l.li () .

0

This distribution of measured thresholds would occur

if the first suprathreshold shock tested were selected
"blindly" with no fixed relation to the true threshold, a
situation which exists in practice.

In this case, the

mean measured threshold would overestimate the true
threshold by 5 percent, and the variance of the distribution
of measured thresholds may be calculated analytically as:

2

a samp 1'1ng =

10
I

I

0

I

2

0

di -

( 1. 0 5 I )
0

2

=

0.00083 I

2
0

Since the mean of the measured values overestimates true
threshold by 5 percent (MI

= 1.05 I 0 ) , one may express the

sampling variance in terms of the mean measured threshold
as
2

a samp 1'1ng

=

0.00076 M

I

2

or

a samp l'1ng = 0.027MI .

Further, since sampling and physiologic variance are
independent phenomena,* the physiologic variance in

*That

is, the variability of the experimenter and the
variability of the animal are not correlated.
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defibrillation threshold current may be estimated as:
2

2

2

2

2

a p h ys1o
. l og1c
. =a o b serve d-a samp 1 1ng
. =0.01188M 1 -0.00076MI

=

0.

01112~-ii

and

aphysiologic

=

O.lOSMI ·

That is, if only physiologic variation were present, the
standard deviation of measured threshold currents would
be 10.5 percent of the mean.

This figure is hardly

different from the 10.9 percent standard deviation observed using the method described in this thesis.

The

sampling variance introduced by testing discrete defibrillator currents differing by 10 percent in amplitude is
negligible compared to the physiologic variance.

Therefore

there appears to be little justification for testing defibrillator currents differing by less than 10 percent in
the routine measurement of defibrillation threshold.
In summary,these studies show repeated fibrillation and
defibrillation are well tolerated by pentobarbitalanesthetized dogs which fibrillate for less than 30 sec.
The experimental manipulations inherent

in defibrillation

studies as described in this thesis do not in themselves
alter the phenomena under investigation.

The precision of

threshold data obtained by the method reported here is
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limited only by physiologic variability of the animal subject
and, in the case of threshold energy, by the mathematical
relationship of energy to current.

Accordingly the pento-

barbital anesthetized dog, prepared as described in this
chapter, is a suitable model for pharmacologic studies of
ventricular defibrillation.
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CHAPTER 3
ALTERATION OF VENTRICULAR DEFIBRILLATION
THRESHOLD BY DRUG TREATMENT

This phase of the investigation was conducted to
determine if selected cardiac drugs which in theory alter
the ventricular defibrillation threshold produce the
anticipated effects in the intact animal.
Treatments Which Alter Sodium and
Potassium Conductance
The following studies were conducted to determine the
effect on ventricular defibrillation threshold of quinidine,
which acts primarily by decreasing sodium conductance, and
of lidocaine, which acts primarily by increasing potassium
conductance.

These ionic mechanisms of action are anti-

cipated to cause an increase in defibrillation threshold.
Method
Twenty pentobarbital anesthetized mongrel dogs served
as subjects.

This anesthetic was chosen because it does

not alter the defibrillation threshold.

Details of the

anesthesia and monitoring have been described in Chapter 2.
In brief, threshold was determined by repeated trials of

75

fibrillation and transchest defibrillation, each with a
damped sinusoidal defibrillator shock of peak current
amplitude 10 percent less than the amplitude of the preceding shock.

The lowest intensity shock able to achieve

defibrillation, and differing no more than 10 percent in
amplitude from a shock which did not defibrillate, was defined as threshold.
The animals were never permitted to fibrillate more
than 30 sec prior to defibrillation and never refibrillated
until arterial blood pressure had returned to a stable level.
The peak voltage and peak current for each shock were recorded on a storage oscilloscope.

Only data from the first

shocks applied after the onset of ventricular fibrillation
were used in the calculation of threshold.

Delivered

energy was calculated as described by Babbs and Whistler
(1978).

The antiarrhythmic drugs used in this study were
quinidine gluconate, injection, U.S.P.

(Lilly), 80 mg/ml

in water vehicle, and lidocaine hydrochloride (Astra),
20 mg/ml, in a water vehicle, pH 6-7.

Quinidine was given

as a single intravenous bolus (50 mg/kg) to 5 dogs.

Lido-

caine was given as an intravenous bolus (3 mg/kg) to 5
dogs and as a constant infusion (0.5 mg/kg/min) to another
5 dogs.

The 5 dogs in the control group received no drug

other than pentobarbital.

Ventricular defibrillation

threshold was determined at 15 min intervals.

Three
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pre-drug control threshold determinations served to
establish a stable baseline for each animal.

The mean of

the first three threshold values was defined as 100 percent
of control and served as the reference for drug effect in
each animal.

Drug induced changes in the ECG were also noted.
Results

Figure 3-1 shows the dramatic elevation of the threshold
current and energy caused by an intravenous bolus of
quinidine gluconate (50 mg quinidine/kg) in 5 dogs.
The data points in Figure 3-1 represent mean threshold
energy and current ratios.

The threshold energy and

current ratios were calculated by dividing the individual
threshold values by the average of the first three ''baseline"
threshold values for each animal.

The period of negative

time on the abscissa represents this baseline.

Threshold

peak current was increased by 70 percent and threshold
delivered energy was increased by 172 percent by 50 mg/kg
of intravenous quinidine gluconate.

This dose was sufficient

to cause systolic blood pressure to fall initially from 170
to 95 mmHg, and diastolic blood pressure to fall initially
from 128 to 60 mmHg.

Thereafter the magnitude of blood

pressure depression gradually diminished at approximately
the same rate as the magnitude of defibrillation threshold
elevation.
Figure 3-2 illustrates a similar elevation of defibrillation threshold by an intravenous bolus of lidocaine
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in a dose of 3 mg/kg.

The maximal elevation of threshold

current was 26 percent and the maximal elevation of
threshold energy was 48 percent.

In contrast to the

threshold elevation observed after intravenous quinidine,
the effect of lidocaine appeared slower in onset.
Administration of lidocaine by continuous intravenous infusion (0.5 mg/kg/min) also caused threshold to rise
continuously in another group of 5 dogs (Figure 3-3) to a
maximum of 199

percent of control energy and 145 percent of

control current after 80 min.

Mean blood pressure fell

from 150 mmHg at the beginning to 110 mmHg at the end of
the lidocaine infusion.
Figure 3-4 illustrates mean threshold energy and
current in the control animals which received no drug other
than pentobarbital anesthesia.

These animals were studied

for a longer period of time than any drug treatment group.
In control animals, threshold energy decreased by about 10
percent during the first hour of testing and thereafter
remained stable.

Mean threshold current did not change

over a period of 280 minutes.
Discussion
Elevation of ventricular defibrillation threshold by
quinidine and lidocaine confirms the predictions of the
theory of defibrillation presented in Chapter 1.

The scheme

of Figure 1-6 predicts that a decrease in sodium conductance
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will have two effects: first, a slight negative shift of the
resting membrane potential, and second, a positive shift
of the transmembrane potential at which the depolarizing
sodium current exceeds the hyperpolarizing potassium current
and generates Phase 0.

As a result the theory predicts

that any agent which decreases sodium conductance would cause
a greater voltage gap between membrane resting and firing
potentialswhich must be overcome by the action of defibrillating current.

In fact, quinidine, a drug which

decreases sodium conductance, did increase the electric
current "dose" for defibrillation.

Lidocaine, however,

acts by increasing potassium conductance at therapeutic
doses.

The theory of Chapter 1 predicts that increased

potassium conductance would decrease the resting membrane
potential slightly and raise the firing threshold at which
inward sodium current exceeds outward potassium current.
In turn, defibrillation threshold would be expected to
increase.

This prediction, too, was confirmed by the

experimental results.

Hence the threshold elevation caused

by antiarrhythmic drugs which alter sodium or potassium
conductance can be understood in terms of the principles of
membrane physiology.
The notion that quinidine and lidocaine acted by
different mechanisms to raise defibrillation threshold
in the present studies is confirmed by the electrocardiographic data.

In theory, decreased transmembrane sodium
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conductance is related to decreased (dV/dt)

0

and in turn to

prolonged QRS complex duration, as explained in Chapter 1.
Lidocaine in higher concentrations is known to have such
a quinidine-like effect (deJong, 1970; Mandel and Bigger,
1971; Weld and Bigger, 1973).

However in the present

study quinidine prolonged the QRS complex duration while
lidocaine did not.

Following quinidine (50 mg/kg, i.v.),

the mean duration of the QRS complex increased 37 percent
and then gradually returned to the control level.

The

mean percent increase in QRS duration was correlated with
the mean percent increase in defibrillation threshold
2
current (r =0.67, p=0.004),

In lidocaine-treated animals,

however, QRS duration remained essentially constant, and
changes in mean QRS duration were not correlated with
changes in mean defibrillation threshold current
2

(r =0.06, p=0.46).

These findings are consistent with

the claim that the effect of lidocaine was produced by a
different ionic mechanism than that of quinidine.
Treatments Which Alter the Potassium
Equilibrium Potential (EKl
Theory predicts that the defibrillation threshold will
not only be altered by changes in the sodium or potassium
conductance of the membrane but also by parallel shifts in
the IK versus Em function of Figure l-6(a), caused by
changes in the potassium equilibrium potential.

The
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objectives of the studies reported in this section were as
follows:
e

To investigate changes in ventricular defibrillation
threshold produced by changes in extracellular potassium
ion concentration (K ) in dogs.
0

e

To hold total body potassium content essentially
constant during the above studies.

•

To measure the intracellular potassium ion concentration
(K.) of the ventricular myocardium.
1

•

To plot defibrillation threshold as a function of
EK=-61.5 log(K./K ) .
1

0

Method
Animal Preparation.
Healthy mongrel dogs weighing 17-20 kilograms served
as subjects.

Anesthesia was induced with intravenous

pentobarbital sodium (25-30 mg/kg) and maintained with
additional 2 mg/kg boluses as necessary.

No other drug

except potassium chloride was administered.

Esophageal

temperature, the electrocardiogram, aortic blood pressure,
respiratory minute volume, and arterial blood pH, pco ,
2
and po

2

were monitored as described in Chapter 2.

One

hour before the beginning of defibrillation threshold
measurements, the right and left ureters were ligated
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through a midline laparotomy and the wound closed with
continuous suture.

A bipolar catheter electrode was

placed in the right ventricle via a jugular venous cut-down
to initiate ventricular fibrillation.
Defibrillation threshold was determined three times
during the 120 min period before potassium administration
and three times during the 120 min period after potassium
administration.

Plasma levels of sodium and potassium in

arterial blood were monitored at 10-20 min intervals using
an Instrumentation Laboratories Model 443 flame photometer.
After the first three pre-drug threshold determinations,
intravenous potassium chloride in a dose of 1.0 mEq/kg
was given slowly over a period of 5-10 min as the electrocardiogram was closely monitored for arrhythmias.
Following this injection, a slow infusion of potassium
chloride at 0.01 mEq/kg/min was begun using a motor driven
syringe.

After stable, elevated levels of plasma

potassium were attained, three more measurements of the
defibrillation threshold were made during the 120 min
following the onset of potassium administration.
Measurement of Intracellular Potassium Concentration.
Following completion of the defibrillation threshold
measurements, the potassium infusion was stopped and median
sternotomy and pericardiotomy were performed.

The heart was

perfused first with lactated Ringer's solution and then with
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5 percent dextrose in water via a cannula placed in the
left bracheocephalic artery.

All other branches of the

aortic arch except of the coronary arteries were ligated.
Before perfusion, the cavae and descending thoracic aorta
were clamped; the atria were cut to promote drainage of
blood and perfusate.

After perfusion with 500 ml of

lactated Ringer's solution, a 1 gram sample of right
ventricular muscle nourished by the left anterior descending
coronary artery was excised for assay of sodium and
potassium content.

Then perfusion with 500 ml of dextrose

solution was carried out and a 1 gram sample of right
ventricular muscle nourished by the right coronary artery
was excised for assay of tissue sodium and potassium content.
The assay procedure employed overnight digestion of the
tissue samples in 10 volumes of 1 molar H so at 80°C.
2 4
Such digestion for 1 hour or longer produced maximal
recovery of sodium and potassium from the pieces of myocardium.

Assay of the supernatant solution for sodium and

potassium concentration was accomplished using an Instrumentation Laboratories Model 443 flame photometer, calibrated
with solutions of 1 molar H so containing known concentra2 4
.
f
+
d
-+
.
tlons o Na an K lons.
Samples of coronary sinus
effluent taken after perfusion with 400 ml of each solution
provided a measure of extracellular sodium and potassium
concentrations in each case.
80-120 mmHg.

Perfusion pressure was always
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Calculation of the Fractional Extracellular Fluid Volume.
Total tissue sodium concentration, Nat, is given by
the expression

=
where

0

0

0.
l

=

volume

=

1-0

0

0

0

Na

+

0

0

.Na.

l

l

fraction of the extracellular space

= volume fraction of the intracellular space

Na.

=

intracellular sodium concentration

Na

=

extracellular sodium concentration.

l

0

Assuming that sodium ions cross intact cell membranes
slowly, total tissue sodium is linearly related to extracellular sodium concentration, with intracellular sodium
remaining constant, when the tissue is perfused with isotonic solutions of differing sodium concentrations.
Hence,

0

0

may be calculated from measurable quantities as

Nat(Ringer's) - Nat(dextrose)
0

= Na (Ringer's)
0

0

Na (dextrose)
0

Calculation of Intracellular Potassium Concentration.
Once

00

is known, intracellular potassium concentra-

tion is then calculated from total tissue and plasma
potassium concentrations as
Kt -

K. =
l

1 -

0.

0

0
0

K

0
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Investigation of Higher Levels of K .
0

The potassium treatment schedule for the 10 animals
just described was designed to produce stable elevations
of extracellular potassium concentration near the maximal
levels tolerated by the animals, without profound hypotension, paralysis of the sinoatrial or atrioventricular
nodes, or intractable tachyarrhythmias.
In preliminary experiments such complications did occur
with more rapid rates of potassium infusion.
To elu6idate the influence of high concentrations
of extracellular potassium upon defibrillation threshold,
an experiment was designed to determine at what concentration of extracellular potassium the ventricles of dogs
would spontaneously defibrillate, that is, at what level
of K

0

defibrillation threshold was zero.

These studies

were carried out in open-chest dogs in whom cardiac output
was maintained by a left ventricular bypass pump.

The

problem of circulatory collapse produced by very high
levels of plasma potassium was thus obviated.
fibrillator was needed for the study.

No de-

Neither was it

necessary to establish a control level of the defibrillation
threshold, since zero threshold current is equivalent to
zero percent of control in any case.
Nine pentobarbital anesthetized dogs served as
subjects for this study.

After median sternotomy and

pericardiotomy had been performed, surgical hemostasis
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secured, and heparin (2 mg/kg i.v.), administered
ventricular fibrillation was initiated by 60 Hz stimulation
of the right ventricular surface.

Each animal was

immediately placed on a La Farge-type left ventricular
bypass system.

As shown in

Figure 3-5, blood was withdrawn from the left ventricle
through a large bore multiple side-hole cannula inserted
through a small stab wound in the cardiac apex.

Blood

withdrawn from the left ventricle was led through a Travenol
roller pump and reinfused into the animal via a large

bore,

right-angle cannula previously placed in the abdominal
aorta.

Prior to institution of the bypass, the tubing was

filled with warmed (30-40°C) Ringer's solution.

Care was

taken to ensure that the left ventricular cannula was not
pushed through the aortic valve from the left ventricle,
since a short circuit would have been created.

To promote

venous return, the animal's hindquarters were elevated
30 degrees and up to 1000 ml of additional Ringer's solution
infused as necessary to maintain a stable artificial
cardiac output.
After the bypass system had been adjusted, potassium
chloride was infused via the femoral vein at a rate of
0.2 mEq/kg/min, calculated to raise the extracellular
potassium concentration by approximately 1 mEq/L/min.
Esophageal temperature, the electrocardiogram, arterial
blood pressure, and arterial blood pH, pco , and po were
2
2
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ROLLER
PUMP

BLOOD
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BUBBLE
TRAP

---------u--~

TO RECORDER
Figure 3-5. Principle of open-chest left ventricular
bypass. The left ventricle, LV, is catheterized
via a stab wound in the cardiac apex. The roller
pump provides an artificial left ventricular
output, which is returned to the abdominal aorta.
The negative pressure created in the left ventricle
and left atrium is sufficient to draw systemic
venous blood through the pulmonary vasculature.
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monitored as described in Chapter 2.

Two arterial blood

samples were taken at the time of spontaneous, chemical
defibrillation for analysis of plasma potassium concentration.

The first sample was taken at the moment fibrillation

appeared to cease, as judged by the electrocardiogram and
direct visual inspection of the heart.

The second sample

was taken when defibrillation was confirmed by electrical
pacing of the ventricles by single 10 volt, 2 msec stimuli
applied to the ventricular surface with hand-held bipolar
electrodes.

Generation of ventricular ectopic beats in

the electrocardiogram was taken as confirmation of
ventricular defibrillation.

The average plasma potassium

concentration of the first and second samples was taken as
the level required for defibrillation with zero current
and energy.
Results
The stable elevation of plasma potassium concentration
produced by the "bolus plus infusion" technique in ten dogs
is illustrated in Figure 3-6.

The technique described

produced a stable plateau of extracellular potassium
concentration for defibrillation studies.

The overall

mean control potassium level was 3.9 mEq/L and the overall
post potassium infusion level was 7.5 mEq/L.
Calculated levels of intracellular potassium concentration
in 4 of these animals and in 4 animals which did not receive prior potassium infusions are given in Table 3-1.
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The mean value for intracellular potassium was 91 mEq/1
and the standard error of the mean was 3.6 mEq/1.
Intracellular potassium concentrations of dogs which received potassium treatment vrerenot significantly different
from those of dogs which did not (t

=

0.66, p

=

0.53).

Figure 3-7 surnmarizes the effects of increased extracellular potassium concentration on ventricular defibrillation threshold.

Defibrillation threshold as percent of

control is plotted as a function of plasma potassium concentration and of calculated potassium equilibrium potential.
The left-hand and middle data points represent mean control
and post-potassium infusion threshold values.

The right-

hand data point represents the mean plasma potassium
concentration for spontaneous defibrillation with zero
current or energy.

The upper scale for potassium equilibrium

potential was calculated from the Nernst equation using
the mean value of intracellular potassium concentration
reported in Table 3-1.

As extracellular potassium concentra-

tion is increased, ventricular defibrillation threshold
dramatically decreased, reaching zero value when K

0

was

16.6 mEq/1 and EK was -46 mV.
Discussion
The theory developed in Chapter 1 predicts that the
defibrillation threshold should be

relat~d

potassium equilibrium potential, EK.

to the

As EK is increased,

the gap between the theoretical equilibria for resting
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Figure 3-7. Effect of elevated extracellular potassium
concentration on ventricular defibrillation
threshold in dogs.
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Table 3-1.
Ionic concentrations in canine ventricular muscle.
cri=volume fraction of extracellular space; Nat=tissue
sodium concentration; Kt=tissue potassium concentration;
Nai=intracellular sodium concentration; Kj_=intracellular potassium concentration. Prior KCl=KCl 1.0
mEq/kg i.v. slowly, followed by KCl 0.01 mEq/kg/min
for 120 min. Student's t tests the null hypothesis
that values for dogs 1-4 (no prior KCl) are equal to
values for dogs 5-8 (prior KCl treatment) . Prior KCl
did not cause significant changes in the tabulated
values.
Dog #

Prior
KCl

0·

1

Nat
mEq/1

Kt
mEq/1

Na.

K.

mEq/1

· mEg/1

l

1

1

no

0.27

37

54

16

77

2

no

0.26

45

82

15

109

3

no

0.15

31

71

14

83

4

no

0.20

36

69

11

85

5

yes

0.26

40

75

7

99

6

yes

0.18

29

73

6

88

7

yes

0.17

34

76

17

90

8

yes

0.24

40

74

8

97

Mean

22

37

72

12

91

S.D.

4.7

5.2

8.1

4.3

10.2

t

0.66

0.38

-0.95

1. 63

-0.66

p

0.53

0.72

0.38

0.15

0.53

(twotailed)
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membrane potential and cellular-firing threshold narrows.
This change in turn is predicted to decrease the defibrillation threshold.

At some value of EK less

negative than normal,theory predicts that defibrillation
threshold is zero.

As indicated in Figure 3-7, the

decrease in defibrillation threshold is in fact related
to the increase in EK, and defibrillation threshold falls
to zero at half the normal negative value of EK.

Thus the

influence upon defibrillation threshold of drugs which alter
the potassium equilibrium potential may also be understood
in terms of fundamental concepts of membrane physiology.
Discussion of Drug Effects on Ventricular
Defibrillation Threshold
Drug effects on defibrillation threshold are of
potential clinical importance because patients who fibrillate
may have been placed on maintenance inotropic or antiarrhythmic drug therapy or admitted to coronary care units
where antiarrhythmic drugs may be given routinely.

Intra-

venous lidocaine by bolus injection or continuous infusion
is currently recommended for hospitalized patients following
acute myocardial infarction for suppression of ventricular
arrhythmias (Hurst, 1974; Rawlings, 1976).

Nonetheless,

patients receiving lidocaine may still fibrillate (Pantridge,
1975) .

A variety of drugs may be given prior to defibrilla-

tion in attempts at cardiopulmonary resuscitation.

Since
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some authors have indicated that present commercial
defibrillators, which store 400 joules of energy, may
have marginal or inadequate output for heavyweight
patients (Tacker, 1974; Collins, 1978), the question of
whether cardiac drugs alter the electrical shock strength
required for defibrillation becomes especially pertinent.
The present studies show that members of three classes
of cardiac drugs alter the energy and current for electrical
ventricular defibrillation.

Quinidine, a drug which acts

primarily by decreasing transmembrane sodium conductance,
and lidocaine, a drug which acts primarily by increasing
transmembrane potassium conductance, raise defibrillation
threshold.

Potassium chloride, a drug which acts by making

potassium equilibrium potential less negative, lowers the
defibrillation threshold.

These findings significantly

augment the literature concerning drug interactions with
defibrillating current.
The only previous report of the influence of antiarrhythmic drugs upon ventricular defibrillation threshold
is that of Woolfolk (1966), who found that quinidine
(10-60 mg/kg, i.v.) decreased the likelihood of successful
ventricular defibrillation in dogs given transchest shocks
of 30, 40, or 50 joules.

The present studies confirm

Woolfolk's conclusion and also demonstrate that failure to
defibrillate in the presence of quinidine may be reversed
by the use of increased electric shock strength.
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Lown (1968) reported that the mean stored energy for
ventricular defibrillation by damped sinusoidal current in
5 dogs, given toxic doses of acetyl strophanthidin and
ouabain, was 42 joules compared to the pre-drug value of
58 joules.

In this study, digitalis glycosides appeared

to decrease defibrillation threshold by 27 percent, although
the difference was not statistically significant.

Lown's

data were obtained in animals given digitalis glycosides
in doses sufficient to produce ventricular tachycardia.
Fibrillation was produced by transthoracic direct current
shocks delivered during the "vulnerable period" of the
cardiac cycle.

The post-defibrillation rhythm was always

ventricular tachycardia, not sinus rhythm.

However, when

ventricular fibrillation was caused by higher doses of
digitalis in three of these animals, the arrhythmia could
not be reverted, even by multiple,high energy shocks.
Tacker (1975) found a dose-related decrease in defibrillation threshold current and energy in dogs following
a single intravenous dose of ouabain.

A dose of 50 vg/kg,

corresponding to that used in Lown's study, produced an
average maximum decrease in threshold energy of 29 percent,
a finding virtually identical to that of Lown.

However,

at a higher dose, 80 vg/kg, Tacker reported that the lethal
mechanism in 2 of 4 dogs was electromechanical dissociation
following successful defibrillation rather than failure to
defibrillate.

Both studies, how·ever, agree that high,
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but not lethal, doses of ouabain decrease the defibrillation threshold.
These findings are consistent with the effects of
potassium reported in this thesis and may be explained as
an indirect effect of the well-known inhibition of
membrane-bound sodium/potassium ATPase by digitalis
glycosides.

This cellular effect of digitalis preparations

causes inhibition of active transport of sodium ions out of
and potassium ions into myocardial cells.

As a result,

there is a net outward leakage of potassium ions (Langer
and Serena, 1970) which conceivably could produce local
elevations in extracellular potassium concentration with
resultant depression of the defibrillation threshold.
These indirect alterations in defibrillation threshold
by induced changes in local extracellular potassium concentration may also explain the recent (unpublished) observation in our laboratories that defibrillation threshold
decreases following durations of fibrillation and total
circulatory arrest lasting more than 2 min.

In addition

to depression of defibrillation threshold, we have found
in preliminary experiments that the potassium concentration
of blood recovered from the coronary vascular bed increases
progressively as the duration of fibrillation and cardiac
anoxia is lengthened.

Such hearts, which have fibrillated

for more than 2 min exhibit hypocontractility following
defibrillation which may be reversed by calcium
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administration or several minutes of cardiac massage
and ventilation ("washing out" of the coronary vascular
bed) .

These preliminary observations lead to the hypothesis

that accumulation of extracellular potassium ions may lead
to depression of both defibrillation threshold and post-defibrillation cardiac contractility after prolonged durations
of fibrillation.

Hence, although elevations of extracellular

potassium concentration as great as those reported in the
present studies would never be produced for therapeutic
reasons, the finding of threshold depression by potassium
may be important in understanding various pathophysiologic
states.
Koning and associates (1973) have reported calcium
and magnesium induced changes in the shock strength required for ventricular defibrillation using dog preparations
in which the coronary circulation was maintained during
fibrillation by means of a bypass pump.

Using a unique

double pulse technique, Koning found that after doubling
the plasma calcium concentration, the second of two shocks
delivered 5-10 msec apart must be increased in amplitude
to achieve defibrillation.

Doubling of plasma magnesium

concentration caused the threshold amplitude of the second
shock to decrease.

These results may be analogous to an

increase in the single shock defibrillation threshold by
calcium and a decrease in the single shock defibrillation
threshold by magnesium.

Such an effect would be predicted
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by the theory developed in Chapter 1 to the extent that
(1) calcium blocks sodium conductance and (2) magnesium
acts as a calcium antagonist.
Although by no means a local anesthetic in most
respects, calcium may have a local anesthetic-like action
upon sodium conductance.

Weidmann (1955) was the first to

study the electrophysiologic properties of calcium in
cardiac tissue.

Using multiple microelectrodes in calf and

sheep Purkinje fibers, this investigator found an increase
in the cellular firing potential from -68 to -61 mV when
extracellular calcium concentration was raised fourfold.
However, since transmembrane resistance was unchanged or
slightly decreased and since (dV/dt)

0

was increased by

added calcium, the author concluded that calcium does not
decrease sodium conductance in the manner of local
anesthetics.
Such a "local anesthetic" effect of calcium ions,
however, has been reported by others in both nerve and
ventricular muscle.

Frankenhaeuser and Hodgkin (19 57)

studied voltage-clamped squid axons bathed by 0, 4, 22,
and 112 mM Ga++ solutions made isotonic with choline and
sodium salts.

They found that increased extracellular

calcium concentration decreased inward sodium current and
transmembrane sodium conductance (gNa) .

The curve relating

gNa to transmembrane potential was shifted 15 mV to the
right (less negative) by a fivefold increase in calcium
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concentration.

That is, 15 mV greater depolarization was

required to produce a given gNa.

Calcium, like local

anesthetics or quinidine, also decreased potassium current
and conductance.

Unlike local anesthetics, however, calcium

did not decrease the maximal sodium conductance.
Beeler and Reuter (1970) developed a voltage-clamp
method utilizing a sucrose gap and glass microelectrodes to
study dog ventricular fiber bundles.

Although these authors

admitted some technical difficulties in measuring large
inward sodium currents during Phase 0, they obtained curves
relating peak transient (inward sodium) current to transmembrane potential (Em) similar to those for squid axon.
In these studies, ventricular muscle activation curves for
gNa were shifted in a parallel fashion toward less negative
voltages by increased extracellular calcium concentration.
The E

m

for 50 percent of maximal activation of gNa was

shifted from -64 mv to -58 mV to -54 mV as extracellular
calci urn was increased from 0. 2 mNl to 1. 8 mM to 7. 2 mM.

To

the extent that such a "local anesthetic" action of calcium
occurred in Koning's defibrillation studies, his finding
of increased second pulse amplitude for defibrillation in
hypercalcemia is consistent with the studies reported in
this thesis using quinidine, a drug which also decreases
sodium conductance.
Perhaps the most useful result of the present investigation is the development of a theory which relates
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ventricular defibrillation threshold to four fundamental
parameters of membrane physiology: gNa, gK, ENa' and EK.
Such a theory readily suggests fruitful areas for further
experimentation.

These include both investigations of

cardiac drugs known to alter gNa, gK, or both such as
procaine amide, diphenylhydantoin, or propranolol, and
investigations of pathophysiologic states which are known
to increase potassium efflux from cells such as hypoxia
(Singh, 1971/72; Lehr and Chau, 1973) or
(Hochrein, 1971/72).

hypertension

These and similar studies, using the

canine model described in this thesis, can be undertaken
with confidence that the data obtained will be stable and
reproducible and will demonstrate any true alterations in
ventricular defibrillation threshold.
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